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Abstract 
 
Biological systems exhibit an enormous complexity upon their structure, components, 
function and controlling systems towards homeostasis. 
This high degree of complexity derives from the diversity of biological processes, namely 
the reactions involved in cellular respiration, which depend on the presence of oxygen, 
fostering an expectable increase in reactive species of oxygen, among others. 
During the past few years, studies towards the causes and consequences about the 
production of free radicals in organisms were performed, along with studies aiming to 
unveil biological targets prone to attack and the possible consequences from these events. 
Actually, nowadays it is clearly known that the biological membranes are the main targets 
of free radical attacks, resulting in peroxidation conditions. In organisms, there are 
natural antioxidants, such as glutathione, uric acid and ascorbic acid, which are able to 
neutralize the action of these reactive species, avoiding the damage caused by them. 
Aiming at studying how the generation of free radicals affect biological stability, several 
experiments were carried out along this thesis, focusing on understanding the role, the 
efficacy and possible interactions between biological membranes and free radicals. 
Moreover, some aspects related to the location of these antioxidants within the membrane 
(hydrophilic/hydrophobic media) and how the products of such reaction can interfere 
with membrane structure were focused. For this, different biomimetic models were 
assessed, namely micelles, liposomes and Langmuir monolayers, using lipid mixtures 
similar to those found in biological membranes. During these work, standards, reference 
compounds for evaluation of peroxidation were applied, including Trolox and vitamin E. 
Moreover, methodologies relying on application of fluorimetric probes were developed, 
aiming to achieve a simple method with optimized experimental conditions in order to 
evaluate peroxidation in different locations of membrane models (aqueous phase, 
interface and lipophilic media). Other biomimetic models were also assessed, with 
different features concerning their size, lamellar structure and lipidic composition, in 
order to enlighten how these variation and complex aspects interfere with the evaluation 
of oxidative or antioxidant capacity of different compounds. 
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Resumo 
 
Os sistemas biológicos exibem uma elevada complexidade no que concerne a estrutura, 
constituição, função e sistemas de controlo da sua homeostase.  
A sua elevada complexidade deve-se à diversidade de processos biológicos a eles inerente, 
nomeadamente as reações envolvidas na respiração celular, cuja dependência de oxigénio 
em muitos deles, acarreta um natural incremento de espécies reativas de oxigénio, entre 
outras. 
Ao longo do tempo foi-se estudando e conhecendo algumas das causas e consequências da 
produção de radicais livres no organismo, assim como o estudo dos seus alvos de ataque e 
possíveis alterações daí resultantes, estando hoje bastante bem relatadas que as 
membranas biológicas pela sua constituição essencialmente lipídica, são um dos maiores 
alvos de ataque de radicais livres com consequente peroxidação. Existem no organismo 
antioxidantes naturais como a glutationa, o ácido úrico e o ácido ascórbico capazes de 
eliminar estas espécies reativas, evitando os danos potencialmente causados por estas. 
No sentido de estudar a forma como a geração destes radicais afetam a estabilidade 
biológica, foram realizados ao longo deste trabalho alguns ensaios com o intuito de 
perceber melhor o papel, a eficácia e as eventuais interações com as membranas biológicas 
dos radicais produzidos, a forma como estes antioxidantes biológicos protegem as 
membranas dependendo da sua localização (meio hidrofílico/meio hidrofóbico), assim 
como os produtos da reação radical/antioxidante poderão interferir com as características 
membranares. Para tal recorreu-se ao uso de diferentes modelos biológicos, 
nomeadamente com a preparação de micelas, lipossomas e monocamadas de Langmuir, 
utilizando misturas lipídicas de composição semelhante à das membranas biológicas. Ao 
longo de todo o trabalho realizado foram utilizados calibradores, compostos de referência 
para estudo de peroxidação lipídica, Trolox e vitamina E. 
Foram ainda utilizadas metodologias envolvendo a utilização de sondas fluorescentes por 
forma a otimizar algumas condições experimentais baseada em metodologia simples, a 
serem utilizadas em estudos de avaliação da peroxidação lipídica, em diferentes 
localizações da membrana (meio aquoso, interface e meio lipofílico). 
Foram estudados modelos biomiméticos distintos em tamanho, número de lamelas e 
composição como forma de incrementar o conhecimento sobre a forma como estas 
variações e complexidade interferem dificultando a avaliação da ação oxidante ou 
antioxidante de diferentes compostos. 
 
Palavras-chave: modelo biomimético, peroxidação, antioxidante 
viii 
 
Tables of Contents 
 
Acknowledgements ............................................................................................. iv 
Abstract ............................................................................................................... vi 
Resumo  .............................................................................................................. vii 
Table of contents  .............................................................................................. viii 
List of figures  .................................................................................................... xiii 
List of tables  ..................................................................................................... xix 
List of abbreviations and symbols  ................................................................... xxi 
 
Chapter 1 
1.General introduction  .................................................................................. 2 
 
1.1 Biological membranes and oxidative stress  .................................................. 2 
1.1.1 Structure and functions of biological membranes  ............................... 2 
1.1.2 Lipid peroxidation  ................................................................................ 4 
 
 
1.2 Oxidative stress  ............................................................................................. 7 
  
1.3 Consequences to membrane and organisms exposed to oxidative stress  .... 9 
 
1.4 Biomimetic sytems  ....................................................................................... 11  
 
1.5 Methods for assessments of antioxidants  .................................................... 13 
 
1.6 Scavenging capacity assays against specific ROS/RNS  ...............................16 
1.6.1 Peroxyl radical (ROO•) scavenging capacity assays  ............................16 
1.6.2 Other ROS/RNS scavenging capacity assay  ...................................... 18 
1.6.3 Scavenging capacity assays against stable, non-biological radicals  
and evaluation of total reduction capacity  ...................................... 20 
 
1.7. Methods for antioxidants assessment with biomimetic structures  ............ 21 
1.7.1 Type of biomimetic systems  ............................................................... 22 
ix 
 
1.7.2 Lipids employed  ................................................................................. 42 
1.7.3 Initiator of oxidation  .......................................................................... 45 
1.7.4 Measurement of oxidation  ................................................................. 45 
1.7.5 Applications  ........................................................................................ 46 
 
1.8 References  ................................................................................................... 47 
 
Chapter 2 
2.Material and methods  ...................................................................... 60 
 
2.Material and Methods  .....................................................................................61 
 
2.1. Introduction .................................................................................................61 
 
2.2. Reagents, solutions and samples  ................................................................61 
 
2.3. Fluorimetric measurements  ...................................................................... 62 
 
2.4. ORAC method – quantification  ................................................................. 63 
 
2.5. Preparation of biomimetic lipid systems  ................................................... 63 
 
2.6. Surface pressure – area measurements in monolayers  ............................ 65 
 
2.7 Brewster angle microscopy (BAM) in monolayers  ..................................... 67 
 
2.8 References  ................................................................................................... 68 
 
  
x 
 
Chapter 3 
3.Insights about α-tocopherol and Trolox interaction with 
phosphatidylcholine monolayers under peroxidation conditions 
through Brewster Angle Microscopy  ...................................................... 69 
 
3.1 Introduction  ................................................................................................. 70 
 
3.2 Reagents and solutions  ................................................................................ 71 
 
3.3 Results  .......................................................................................................... 71 
3.3.1 π-A measurements  .............................................................................. 71 
3.3.2 BAM observation  ................................................................................77 
 
3.4 Discussion and conclusions  ........................................................................ 81 
 
3.5 References  ................................................................................................... 89 
 
Chapter 4 
4.Interaction of soluble biological antioxidants with 
phosphatidylcholine monolayers  ............................................................ 94 
 
4.1 Introduction ................................................................................................. 95 
 
4.2 Reagents and solutions  ............................................................................... 97 
 
4.3 Results  ......................................................................................................... 97 
 
4.3.1 π-A measurements  ............................................................................. 97 
 
4.3.2 BAM observation  ............................................................................. 103 
 
4.4 Discussion  ........................................................................................... 106 
 
4.5 References ........................................................................................... 108 
xi 
 
Chapter 5 
5.Evaluation of antioxidant capacity using lipidic biomimetic 
structures  ...................................................................................................... 111 
 
5.1Introduction ................................................................................................. 112 
 
5.2 Reagents and solutions  .............................................................................. 113 
 
5.3 Preparation of lipid structures  ................................................................... 114 
 
5.4 Assessment of antioxidant capacity  ........................................................... 114 
 
5.5 Calculation of antioxidant capacity as area under curve  ................................... 115 
 
5.6 Results and discussion  ............................................................................... 115 
5.6.1 Characterization of structures  .......................................................... 115 
5.6.2 Oxidation profile of fluorescein probe  ............................................. 116 
5.6.3 Application to antioxidants  .............................................................. 117 
 
5.7 Conclusions  ................................................................................................ 118 
 
5.8 References  .................................................................................................. 119 
 
Chapter 6 
6. High-throughput fluorimetric methodologies for assessment of 
antioxidant capacity of drugs at different locations of phospholipid 
bilayer  ............................................................................................................. 121 
 
6.1. Introduction .............................................................................................. 122 
 
6.2. Materials and methods  ............................................................................ 124 
 
6.2.1 Chemicals  ......................................................................................... 124 
 
xii 
 
6.2.2 Preparation and fluorescence labeling of liposomes  ...................... 124 
6.2.3Microplate fluorimetric protocols for assessment of the 
antilipoperoxidant effects of drugs  ........................................................... 125 
6.2.4 Calculation of antioxidant capacity values expressed as IC50 or IC25 126 
6.3. Results and discussion  ....................................................................... 127 
6.3.1 Influence of probe concentration  .................................................... 128 
6.3.2 Influence of lipid and AAPH concentration .................................... 129 
6.3.4 Ability of NSAIDs to counteract lipid peroxidation in different locations 
of phospholipid bilayers  ............................................................................ 133 
 
6.4. Conclusions  .............................................................................................. 139 
 
6.5 References  ................................................................................................. 139 
 
Chapter 7  .................................................................................................... 143 
General conclusions  .................................................................................. 144 
 
xiii 
 
List of figures 
 
 
Chapter 1 
General introduction 
 
Figure 1.1 Representation of the chain-reaction process and inhibition in the 
presence of antioxidants.  
 
Figure 1.2 Classification of inducers of lipid peroxidation.  
 
Figure 1.3 Schematic representation of equation and its components applied for 
calculation of peroxidation rate. 
 
Figure 1.4 Schematic relationship oxidative stress and tissue injury. 
 
Figure 1.5 Representation of the relationship between Food and/or drugs with 
Equilibrium, health or disease.  
 
Figure 1.6 Schematic illustration of : (A) structure of the micelles; (B) liposomes 
structure (size and lamellarity); (C) Monolayer representation.  
 
Figure 1.7. Schematic representation of competitive and non-competitive 
approaches, for in vitro determination of antioxidant capacity.  
 
Figure 1.8 Schematic representation from the net integrated area under the 
fluorescence decay curves.  
 
Figure 1.9 Physical and chemical factors that affect the peroxidation of liposomal 
lipids.  
 
Figure 1.10 Molecular structure of thermolabile azo-compounds used for 
generation of peroxyl radicals. 
 
xiv 
 
Chapter 2 
Material & methods 
 
Figure 2.1 Schematic representation of techniques used in this work for 
preparation of biomimetic systems. 
 
Figure 2.2 Isotherm representation, of DPPC monolayer obtained with a NIMA 
601 (Nima Technology, Coventry, UK) Langmuir trough (total area = 600 cm2; 
subphase volume c.a. 400 mL of the phosphate buffer) and BAM images at 
different pressures and lipid phases (LE-lipid expanded; LE/LC-lipid 
expanded/lipid condensed; LC - lipid condensed and monolayer collapse). 
 
Chapter 3 
Insights about α-tocopherol and Trolox interaction with 
phosphatidylcholine monolayers under peroxidation conditions 
through Brewster Angle Microscopy 
 
Figure 3.1 Surface pressure-area isotherms of monolayers formed by DPPC (■), 
DPPC + LA (●) and EPC (▲) upon a phosphate buffer (pH 7.4) subphase. 
 
Figure 3.2 Surface pressure-area isotherms for different lipid systems, with 
monolayers formed and compressed above subphases containing phosphate buffer 
pH 7.4 (■), AAPH solution (●), Trolox solution (▲) and AAPH + Trolox solution 
(▼). A: DPPC ; B: DPPC + LA; C: EPC. 
 
Figure 3.3 Surface pressure-area isotherms for lipid systems containing α-
tocopherol, with monolayers formed and compressed above subphases containing 
phosphate buffer pH 7.4 (without α-tocopherol: ■; with α- tocopherol: ▲) or 
AAPH solution (without α-tocopherol: ●; with α-tocopherol: ▼). A: DPPC ; B: 
DPPC + LA; C: EPC. 
 
Figure 3.4 Brewster angle micrographs of DPPC monolayer at different surface 
pressures upon monolayer compression. 
 
xv 
 
Figure 3.5 Brewster angle micrographs of DPPC + LA (A-C) and EPC (D-F) 
monolayers at different surface pressures upon monolayer compression. 
 
Figure 3.6 Brewster angle micrographs showing representative features for 
monolayers of DPPC and DPPC + LA. A, DPPC monolayer with AAPH in the 
subphase; B, DPPC monolayer with Trolox in the subphase; C, D, DPPC monolayer 
with AAPH and Trolox in the subphase; E, DPPC monolayer with α-tocopherol; F, 
DPPC monolayer with α-tocopherol and AAPH in the subphase; G, DPPC + LA 
monolayer with AAPH in the subphase; H, DPPC + LA monolayer with AAPH and 
Trolox in the subphase. 
 
Figure 3.7 Brewster angle micrographs showing representative features for 
monolayers of DPPC + LA and α-tocopherol in phosphate buffer subphase (A-D) 
or with AAPH in the subphase (E-H). 
 
Figure 3.8 Schematic representations of interaction between monolayer and 
aqueous phase components. 
 
Figure 3.9 Domain patterns formed in DPPC monolayers for surface pressures of 
10 and 30 mN m-1 in absence of antioxidants and in presence of either α-
tocopherol or Trolox. 
 
Chapter 4 
Interaction of soluble biological antioxidants with phosphadylcholine 
monolayers 
 
Figure 4.1 Surface pressure-area isotherms for different lipid systems, with 
monolayers formed and compressed above subphases containing phosphate buffer 
pH 7.4 (▬), AAPH solution (▬), glutathione solution (▬), and AAPH + 
glutathione solution (▬). The solid bars represent the area per DPPC molecule 
where LC domains can be visualized by BAM. 
 
xvi 
 
Figure 4.2 Surface pressure-area isotherms for different lipid systems, with 
monolayers formed and compressed above subphases containing phosphate buffer 
pH 7.4 (▬), AAPH solution (▬), ascorbic acid solution (▬), and AAPH + ascorbic 
acid solution (▬). The solid bars represent the area per DPPC molecule where LC 
domains can be visualized by BAM. 
 
Figure 4.3 Surface pressure-area isotherms for different lipid systems, with 
monolayers formed and compressed above subphases containing phosphate buffer 
pH 7.4 (▬), AAPH solution (▬), uric acid solution (▬), and AAPH + uric acid 
solution (▬). The solid bars represent the area per DPPC molecule where LC 
domains can be visualized by BAM. 
 
Figure 4.4 BAM images obtained for different monolayers (DPPC, DPPC + LA and 
EPC), with AAPH and/or antioxidants in the subphase (glutathione, ascorbic acid 
or uric acid). 
 
 
Chapter 5 
Evaluation of antioxidant capacity using lipidic biomimetic structures 
 
Figure 5.1 Fluorescein oxidation profile in presence of different biomimetic 
structures 
 
Figure 5.2 Fluorescein oxidation profile in presence of different biomimetic 
structures and antioxidant Trolox. 
 
Chapter 6 
High-throughput fluorimetric methodologies for assessment of 
antioxidant capacity of drugs at different locations of phospholipid 
bilayer 
 
xvii 
 
Figure 6.1. Fluorescence intensity upon reaction time for different concentrations 
of lipophilic probe C11-BODIPY581/591 obtained in the presence of 10 mM of AAPH. 
The concentration ratio between large unilamellar vesicles of egg L-α-
phosphatidylcholine (EPC) and fluorogenic probe was fixed at 300:1, respectively. 
Figure 6.2. Fluorescence intensity obtained for fluorescent hydrophilic probe 
(fluorescein), fluorescent interface probe (5-dodecanoylaminofluorescein, DDAF) 
and for fluorogenic lipophilic probe C11-BODIPY581/591 in the presence of different 
concentrations (µM) of large unilamellar vesicles of egg L-α-phosphatidylcholine 
(EPC). Fluorescein was added to LUV suspension immediately before the 
measurements, while the DDAF and C11-BODIPY581/591 were incorporated during 
vesicles preparation. For experiments using C11-BODIPY581/591, the concentration 
of peroxyl radical generator (AAPH) was fixed at 10 mM. The circles show the EPC 
concentration selected for further studies. 
 
Figure 6.3. Relative fluorescence intensity (%) of fluorescein (6 nM), DDAF (50 
nM) and C11-BODIPY581/591 (50 nM) in the presence of large unilamellar vesicles of 
egg L-α-phosphatidylcholine (EPC) (800 µM) and different concentrations (µM) of 
peroxyl radical generator AAPH: A) (1) 0, (2) 25, (3) 50, (4) 75, (5) 100, (6) 150, (7) 
200; B) (1) 0, (2) 25, (3) 50, (4) 75, (5) 100, (6) 150; C) (1) 5; (2) 10, (3) 25, (4) 50, 
(5) 75. The arrows indicate the concentration of AAPH (50 mM) that was selected. 
 
Figure 6.4. Relative fluorescence intensity (%) of fluorescein (A and B) and 
antioxidant capacity (C and D) obtained in the presence of different concentrations 
of indomethacin (0, 5, 10, 15, 20 µM) and tolmetin (0, 5, 10, 15, 20, 30, 40 µM) in 
large unilamellar vesicles of EPC (800 µM) and with the AAPH concentration (50 
mM). Antioxidant capacity was determined using the following equation, 
[(AUCTrolox/NSAIDs ‒ AUCblank) / (AUCblank)] x 100. For both drugs, AUC was 
calculated after 240 min. LUV:FL, correspond to the fluorescent intensity obtained 
by liposomes in the presence of aqueous fluorescent probe (fluorescein) in the 
absence of peroxyl radical species. 
 
xviii 
 
Figure 6.5. Relative fluorescence (%) intensity of lipophilic fluorogenic probe C11-
BODIPY581/591 in the presence of large unilamellar vesicles of EPC (800 µM), 
AAPH concentration (50 mM) and different concentrations of Trolox (0, 4, 8, 12, 
16, 20 µM), etodolac (0, 5, 10, 15, 20, 30 µM) and indomethacin (0, 5, 10, 15, 20, 
30 µM). The numbers (1 to 6) correspond to increasing concentrations of Trolox or 
NSAIDs. Relative fluorescence was determined by dividing the fluorescence 
intensity at a given time by the maximum of fluorescence intensity obtained for 
probe’s oxidation in the absence of antioxidant species (see section 2.4). 
 
xix 
 
List of tables 
 
 
Chapter 1 
General introduction 
 
Table 1. Principal reactive species (non radicals) free radicals presents in organism.  
 
Table 2. Principal reactive species (non radicals) presents in organism. Adapted 
from (Halliwell and Gutteridge, 2007) 
 
Table 3 Methods for assessment of antioxidant capacity using LUVs 
 
Table 4 Methods for assessment of antioxidant capacity using MLVs 
 
Table5 Methods for assessment of antioxidant capacity using SUVs 
 
Table 6 Methods for assessment of antioxidant capacity using other biomimetic 
systems 
 
Chapter 3 
Insights about α-tocopherol and Trolox interaction with 
phosphatidylcholine monolayers under peroxidation conditions 
through Brewster Angle Microscopy 
 
Table 3.1. Characteristic parameters (elastic modulus, collapse pressure and 
collapse area) of the Langmuir monolayers tested on aqueous subphases 
containing the peroxidation inducer (AAPH) and antioxidants (Trolox and α-
tocopherol) 
  
xx 
 
Chapter 4 
Interaction of soluble biological antioxidants with phosphadylcholine 
monolayers 
 
Table 4.1. Characteristic parameters (elastic modulus, collapse pressure and 
collapse area) of the Langmuir monolayers tested on aqueous subphases 
containing the peroxidation inducer (AAPH) and antioxidants (glutathione, 
ascorbic acid, uric acid) 
 
Chapter 5 
Evaluation of antioxidant capacity using lipidic biomimetic structures 
 
Table 5.1. Sensitivitya (relative fluorescence × min × µM-1) for antioxidants in 
presence of different biomimetic structures 
 
Table 5.2. Ratioa between the sensitivities attained for a given antioxidant and that 
attained by Trolox in presence of different biomimetic structures 
 
Chapter 6 
High-throughput fluorimetric methodologies for assessment of 
antioxidant capacity of drugs at different locations of phospholipid 
bilayer 
 
Table 6.1. Peroxyl radical scavenging capacity of Trolox and nonsteroidal anti-
inflammatory drugs (NSAIDs) expressed as IC50 and IC25 values obtained with 
fluorescein and with 5-dodecanoylaminofluorescein (DDAF) as fluorescent probes. 
 
  
 
 
 
 
 
 
  
CHAPTER 1 
General introduction 
 
Chapter 1: General introduction 
 
2 
 
1. INTRODUCTION 
 
 
1.1 Biological membranes and oxidative stress 
 
 
1.1.1 Structure and functions of biological membranes 
 
 
The cells are the basic structural and functional unit of organisms and, at the same time, 
they are highly organized with many functional organelles constituted by one or more lipid 
membranes (Demel et al., 1967).  
Each biological cell is enclosed by its outer plasma membrane which controls the 
interaction between the cell and its environment. This applies both to the relatively small 
cells of bacteria or prokaryotes, which have no cell nucleus and without defined 
compartments, and to the much larger cells of eucaryotes, which have such a nucleus and 
compartments delimited. The latter class of cells is present in all animals and plants as 
well as in single-celled microorganisms such as amoeba or yeast (Lipowsky and 
Sackmann, 1995). Furthermore, all eukaryotic cells contain internal membranes which 
represent the boundaries of the internal organelles such as the nucleus, mitochondrial, 
Golgi complex, chloroplasts, among other structures. 
The fluid mosaic model introduced the idea that membranes were formed by a fluid 
bilayer in which proteins and lipids could move freely (Singer, 1993). Nowadays, the 
extended fluid mosaic model contemplates additional structural and functional restraints 
on membrane organization (Vereb et al., 2003). 
One general construction principle which has emerged from molecular cell biology is the 
use of membranes of different composition, organization, complexity and diversity, in 
order to organize space into different compartments (Lipowsky and Sackmann, 1995). 
The basic function of biomembranes is to provide different spatial compartments and to 
act as a highly selective barriers for the exchange of molecules between the different 
compartments, sustaining the concentration gradients between theses compartments, 
fostering signal transduction and mechanical support (Escribá et al., 2008). 
As indicated all membranes of eukaryotic cells separate functional compartments, but the 
cell surface membrane - the plasma membrane - is an extreme. It is the frontier, with 
different physical and functional properties. The plasma membrane is composed by a lipid 
bilayer (Edidin, 2003), ensuring the above mentioned functions because it is composed of 
specific mixtures of different lipids (mainly amphiphilic) and proteins. 
Biological membranes are centrally involved in the control and execution of a great variety  
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of cellular process, thus requiring the maintenance of their proper structure and function 
(Brown and London, 1998; Kinnunen, 1991; Kinnunen et al., 1994), and this is correlated 
with their composition, essentially lipid bilayer to which proteins and carbohydrates may 
be associated or covalently linked. 
The lipids are a heterogeneous group, with amphiphilic structure, with a hydrophilic head 
group and usually two lipophilic hydrocarbon chains. The essential characteristic of the 
lipids is its insolubility or very low solubility in water. Lipids have also been acknowledged 
as key elements in numerous processes (Escribá et al., 2008). Despite the matrix of lipids, 
whose structure and composition is far from simple, due to the number of different lipid 
molecules found in the plasma membrane (that can exceed 1000). The high number of 
structures formed by lipids in vitro indicates that the structural properties of membranes 
can greatly vary in vivo, since the interaction of lipid molecules to form membranes is not 
determined by covalent bonds, like it is with amino acids in proteins (Escribá et al., 2008). 
Membrane lipids can be classified into three main groups: i) Glycerol-based lipids, ii) 
cholesterol and iii) ceramide-based sphingolipids.  
Furthermore, glycerophospholipids can be classified according to their headgroup, 
originating: phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine, 
phosphatidylglycerol and phosphatidylinositol 4,5-bisphosphate. 
In the membranes, the lipids aggregate and form bilayers, which are two-dimensional 
systems, with thermodynamic phases, e.g, fluid phase at high temperatures and one or 
several gel or solid-like phases at low temperatures. Membrane lipids participate in 
dynamic interactions that facilitate changes in their relative position in membranes, and 
that determine membrane thickness, surface packing, along with lateral and rotational 
mobility (Escribá et al., 2008). Hence, it is a difficult task to study the membrane 
structure because it presents polymorphisms, requiring a variable composition to act as 
mimetic to the biological membranes (Cullis et al., 1996). 
One of the most important components of biomembranes is cholesterol that interacts with 
the phosphate headgroup of phospholipids, whereas the bulky steroid region interacts 
with phospholipid acyl chains, bearing an important role in regulating membrane fluity, 
membrane packing, non-lamellar phase propensity and the formation of microdomains. 
The proteins present on membrane, also have many functions, correlated with their 
position. Their role includes allowing the passage of substances into and out of the cell, 
acting as receptors of the membrane, receiving signals from substances that carry a 
message to the cell, promoting the adhesion of adjacent cells in a tissue, working as an 
anchor point for the cytoskeleton (Cullis et al., 1996). Therefore, most of the important  
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roles in membranes have been attributed to the membrane proteins. Hence, the proteins 
can inserted into the membrane or partially integrated into it, being designated as 
intrinsic or extrinsic proteins, respectively. 
The transmembrane proteins have many interactions with lipids pertaining to 
membranes, because these last molecules interact with amino acids from the proteins in 
the hydrophobic environment of the membrane core while the interactions taking place at 
the interface are more less defined, and to a certain extent regulated by the features of the 
proteins (Escribá et al., 2008).  
Furthermore, both lipids and proteins interact for determining the barrier function in the 
cells and they may be both subjected to regulatory processes in response to 
pathophysiological situations or nutritional/pharmacological interventions, which in turn 
may alter the activity and functions of the membrane.(Escribá et al., 2008) Lipids and 
proteins may respond to environmental situations and conditions, which can promote 
changes in the structure and function, consequently causing changes in cell functions, 
their homeostasis, communication and responses. 
In conclusion, membranes constitute a meeting point for lipids and proteins, both 
fulfilling prominent roles in almost all cellular processes. 
 
 
1.1.2 Lipid peroxidation 
 
 
The lipids are the most studied components of the membrane, including aspects 
pertaining to its oxidation, because of they susceptibility, as one important target to attack 
by free radicals (the direct promoters of peroxidation). Hence, the lipid peroxidation 
products (Figure 1) are frequently used as to assess indices oxidative stress, usually 
coming from attack by free radicals to polyunsaturated fatty acids. 
Lipid peroxidation plays a central role in many physiologic and pathological processes 
(Mattson, 2004; Poon et al., 2004a; b; Schnitzer et al., 2007b), and may be promoted by 
different inducers, as depicted in Figure 2. 
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Figure 1.1: Representation of the chain-reaction process and inhibition in the presence of 
antioxidants. Adapted from (Stojanovic et al., 2001)  
 
 
 
Figure 1.2: Classification of inducers of lipid peroxidation. Adapted from (Schnitzer et al., 
2007b) 
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Therefore, much effort has been devoted to gain understanding about the mechanism 
responsible for peroxidation, especially in the context of oxidative stress-related diseases. 
The lipid compounds representing the end-products of these pathways must bestow 
significant evolutionary advantages to the cellular or multicellular systems in which they 
reside, implying particular functional roles for each component (Cullis et al., 1996). 
Peroxidation may also be induced by free radicals, that produced within the system (e.g. 
upon metal-catalyzed decomposition of preformed hydroperoxides). The free radicals, 
involved in many biochemical and physiological processes, are formed due to the 
continuous use of oxygen by aerobic cells and their level are kept under control by the 
different endogenous antioxidants which remove oxidizing species at a similar rate at 
which they are formed (Gutierrez et al., 2003). 
 
 
 
Figure 1.3: Schematic representation of equation and its components applied for 
calculation of peroxidation rate. Adapted from (Halliwell and Gutteridge, 1999) 
 
 
The rate of peroxidation (V) is given by Figure3. When the rate of free radical production 
is constant and the membrane is homogeneous, the dependence of peroxidation on 
membrane properties is governed by the two rate constants: Kp and Kt. The first is the rate 
constant of propagation of the free radical chain reaction and second is the rate constant 
of termination of the chain reaction. 
Biomembranes may possess different susceptibility to lipid peroxidation since they 
contain proteins, antioxidants, cholesterol and different kinds of lipids (Udilova et al., 
2003). 
  
Ri
2Kt
V = Kp [LH] √
√Ri2Kt
Kp
[LH]
Kp is the rate constant of propagation of the free radical chain
reaction.
[LH] is the concentration of oxidizable lipids in the relevant
compartments, namely in the bilayer or in the relevant
compartments
Stead y- state concentration free radicals: square root of the
ratio between the rate of free radical production (Ri) and the
rate constant of termination of the chain reaction (Kt).a)
b)
c)
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1.2 Oxidative stress  
 
 
All organisms are exposed to stressful conditions such as oxidative stress due to metabolic 
reactions (Costantini and Verhulst, 2009), but the term “oxidative stress” cannot be 
defined in universal terms, possibly because there are several types of “oxidative stress” 
due to the complexity of the biological systems and the mechanism of peroxidation (Dotan 
et al., 2004). Therefore, the term oxidative stress is defined intuitively and qualitatively, 
resulting in apparent inconsistencies between the results of different studies where this 
term is not well defined. The most common definition of oxidative stress is the imbalance 
between the concentrations of reactive species of oxygen and nitrogen (ROS and RNS, 
respectively) and the defense mechanisms of the body (Dotan et al., 2004; Pinchuk et al., 
2012; Sies, 1986). 
Nevertheless, some other definitions are also applicable, namely: 1) The rate at which 
oxidative damage is generated (Costantini and Verhulst, 2009); 2) Existence or 
development of oxidative damage attributed to species considered as markers of this type 
of damage. We proposed that the term oxidative stress of any given type (Dotan et al., 
2004) is context-dependent and that oxidative stress evaluation should be based on the 
use of the most sensitive probe of oxidative damage (Dotan et al., 2004) ; 3) Is possible to 
quantify the oxidative stress with the ratio between the lag in presence and absence of the 
studied antioxidant (Pinchuk et al., 2012). 
In some definitions for oxidative stress the idea that it is continuous variable and unlikely 
to ever be exactly zero is implicit since pro-oxidants are continually produced and some 
oxidative damage is always generated (Costantini and Verhulst, 2009). 
The term or concept of the “oxidative stress” appears associated a to lipid peroxidation, 
because the lipids are labile components of membranes prone to oxidation, and therefore 
potentially affected causing changes in membrane properties and, consequently, structure 
and function. In this context, the biomedical literature is full of claims that free radicals 
and other reactive species (RS) are involved in human diseases (Halliwell and Gutteridge, 
2007). 
In the Table 1 and 2 presents a list of reactive species (RS) involved in biological oxidative 
stress. 
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Table 1.1. Principal reactive species (non radicals) free radicals presents in organism. 
Adapted from (Halliwell and Gutteridge, 2007). 
Free radicals Nomenclature Types Formula 
Reactive oxygen species  ROS Superoxide O2•- 
Hydroxyl OH• 
Hydroperoxyl HO2• 
Carbonate CO3•- 
Peroxyl RO2• 
Alkoxyl RO• 
Carbon dioxide CO2•- 
Singlet  O21∑g+ 
Reactive chlorine species  RCS Atomic chloride Cl• 
Reactive Bromine species RBS Atomic bromine Br• 
Reactive nitrogen species RNS Nitric oxide NO• 
Nitrogen dioxide NO2• 
Nitrate NO3• 
 
Table 1.2. Principal reactive species (non radicals) presents in organism. Adapted from 
(Halliwell and Gutteridge, 2007) 
Non radicals Nomenclature Types Formula 
Reactive oxygen species ROS Ozone O3 
Singlet oxygen 1O2 
Hydrogen peroxide H2O2 
Hypochlorous acid HOCl 
Peroxynitrite anion ONOO- 
  Peroxynitrite anion ONOO- 
Peroxynitrous acid ONOOH 
Alkyl peroxynitrite ROONO 
Nitroxyl anion NO- 
Nitrosyl cation NO+ 
Nitronium anion NO2+ 
Nitrous acid HNO2 
Dinitrogen trioxide N2O3 
Dinitrogen tetraoxide N2O4 
Nitryl chloride NO2Cl 
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1.3 Consequences to membrane and organisms exposed to oxidative 
stress 
 
 
Peroxidation of lipids, particularly polyunsaturated fatty acid residues (PUFA) of 
phospholipids and cholesterol esters, and consequently, oxidative stress in cells and 
organism, is a process of marked implications (Pinchuk et al., 2012), therefore it is 
generally accepted that such an imbalance plays a pivotal role in many pathologies (Dotan 
et al., 2004). 
The consequences of oxidative stress can include any, or any combination of, the 
following, to an extent that depends on the cell type and the severity of the oxidative 
stress, including increased proliferation, adaptation of the cell or organism by 
upregulation of defence systems (completely protecting against damage or protecting 
against damage to some extent but not completely or over protect), cell injury, senescence, 
and ultimately cell death (Halliwell and Gutteridge, 2007). 
For an organism exposed to oxidative stress, it is important to evaluate its “oxidative 
status” from the composition of its body fluids and tissues with respect to oxidation 
products, promoters and/or inhibitors of peroxidation.  
Regarding membrane biophysics, it is possible to establish a causal relationship between 
chemical and biophysical consequences of lipid peroxidation (Schnitzer et al., 2007b). 
Essentially, the peroxidation of polyunsaturated fatty acid residues of membrane 
phospholipids result in changes of the membrane composition, which also alter the 
physical properties of the membrane (Schnitzer et al., 2007b).The peroxidation of lipids is 
usually accompanied by oxidation of membrane proteins (Mattson, 2004), thus, all 
oxidation processes affect the composition, packing, fluidity, structure and function of the 
biological membranes. Hence, the but the evaluation of the consequences to membrane is 
indeed difficult, because of the various and complexes process and consequently, in many 
cases, the results of different studies are apparently contradictory, namely concerning 
conclusions regarding “fluidization” or ”rigidization” of the biological membranes as 
consequence of the peroxidation. (De Guidi et al., 2005; Marathe and Mishra, 2002) 
Upon these changes in biological membranes, the organisms are affected. In fact, there are 
various studies in the literature about the effect of oxidative stress and lipid peroxidation  
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in cytotoxicity, cellular damage, pathogenesis of cancer, genetic alterations, diabetes 
mellitus, cardiovascular pathologies (atherosclerosis), different malignant diseases 
(rheumatoid arthritis, cystic fibrosis, intestinal ischaemia), virus infections (including 
AIDS), and neurodegenerative diseases (Halliwell and Gutteridge, 2007; Schnitzer et al., 
2007b; Udilova et al., 2003) (including over 150 disorders)(Costantini and Verhulst, 
2009). 
However, in most diseases, oxidative stress is a consequence and not a cause of the disease 
(Figure 1.4), for example, many of the biological consequences of excess radiation 
exposure are due to oxidative damage and dietary deficiencies (Halliwell and Gutteridge, 
2007). 
Although it has not been yet conclusively understood if reactive species are a cause or 
consequence, the answer probably differs for each pathological condition and may even 
differ from patient to patient depending on his/her antioxidant oxidative defence status. 
 
 
 
Figure 1.4: Schematic relationship oxidative stress and tissue injury. 
 
 
All these observations suggest that oxidative stress plays a role in human diseases taking 
to the proposal that health might be improved by increased dietary intake of antioxidants 
(Ames et al., 1993), because there exist a health balance between oxidants (such as free 
radicals) and antioxidants (such as vitamins E and C and protective enzymes) in vivo 
(Baublis et al., 2000). Beyond these, drugs (including both prescription only and over the 
counter medicines) with antioxidant indications may also have a functional relationship 
between health status and disease state (Aruoma, 1996; Pryor, 1982). This role that food 
and drugs might play in the management of health is shown schematically in Figure 1.5. 
  
Tissue injury
Oxidative Stress
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Figure 1.5: Representation of the relationship between Food and/or drugs with 
Equilibrium, health or disease. Adapted from (Aruoma et al., 1998) 
 
 
1.4 Biomimetic sytems  
 
 
Over time, the need to study the structure and dynamic changes in biomembranes (and 
consequently in the organisms) couple to addressing the problem of applying 
methodologies that are not comparable to biological systems, biomimetic systems, such as 
liposomes, have been employed (Lúcio et al., 2007) in order to try to make conditions 
more closer to those found in vivo. 
Several types of model structures have been employed so far, including here liposomes. 
Liposomes are in fact an important system in their own right in medical, cosmetic and 
industrial applications (Samuni et al., 2000), however, in many cases their instability 
upon storage is one of the major obstacles to their more spread use. 
For investigating the basic characteristic of lipid membranes, simpler models, such as 
micelles, are also applicable. They are usually formed by a surfactant, for example 
miltefosine (hexadecylphosphocholine, HePC). HePC is an current used as alternative  
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drug to reduce and postpone the emergence of resistance of the protozoan parasite 
Leishmania donovani (usually fatal if untreated) upon conventional therapy for Visceral 
Leishmaniasis with pentavalent antimonials (Menez et al., 2007; Rangel-Yagui et al., 
2005). Furthermore, HePC is a structural analogue of phospholipids, therefore a good and 
simple biomimetic system that, form a micellar system, which have been used to increase 
the aqueous solubility of hydrophobic compounds. However, in order to have formation of 
micelles, it is necessary to use concentrations higher than critical micellar concentration 
(CMC), which can pose problems for expensive lipids or can cause spectral interferences 
upon measurements. 
Liposomes constitute a system used in investigation for commercial application (cosmetic 
area, among others), medical and pharmaceutical industry (as previously mentioned) with 
special attention to its physical properties, protocol for preparation, formation and fusion 
mechanism, pH gradients, membrane transport, capabilities, and interaction with 
biological structures (Santos, 2002). Indeed, liposomes are colloidal vesicles where a 
membrane is formed by one or more phospholipids (having a hydrophobic tail and a 
hydrophilic head to assemble the vesicular structures) bilayers. Liposomes have been 
classically applied as a drug carriers, as many kinds of molecules can be encapsulated in 
this inner phase while hydrophobic molecules can be trapped in the bilayer of the lipid 
membrane. In addition, liposomes can be modified with different molecules anchored at 
the surface, applied as biomimetic systems (Kojima et al., 2008), with special interest to 
areas, mostly due to their well characterized membrane properties. 
The liposomes most frequently used are the large unilamellar vesicles (LUVs), with 
diameters larger than 100 nm and the small unilamellar vesicles (SUVs), with diameters 
between 20 to 50 nm. There structure is well bearing simple interpretation for interaction 
phenomena, comparatively to multilamellar vesicles. There are also oligolamellar vesicles 
(OVs), namely SOV, LOV and GOV, corresponding to small, large and giant variants, 
respectively (Figure 1.6). 
Beyond the size and lamellar number, the chemical nature of the phospholipids that 
constitute of utmost importance because they determine other parameters of the vesicles 
structures, namely the charge, the stability, the membrane phase, the curvature of 
bilayer(s) and the formation of domains.  
Other model frequently applied as a membrane surrogate is composed by monolayers, 
which have been known considerably longer before than micelles or liposomes. The 
amphiphilic nature of the substances dictates the orientation of the molecules at the 
interface (air/water). Lipid monolayers are very well defined, stable, homogeneous 
bidimensional systems with planar geometry. Although monolayers do not reflect the 
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complexity of membrane structure, they are considered useful models to learn about 
interactions at interfaces (Deleu et al., 2005) a 2D system. 
Therefore, the various available models of biomembranes: micelles, liposomes and 
monolayers, can be select for the studies pertaining to interactions with biological 
membranes. In Figure 5 the structure of these models, concerning its size and lamellarity, 
are represented. 
As mentioned previously, it is possible to study many properties/characteristics of the 
biological membranes with the use of liposomes, including their applications to studies of 
peroxidation of liposomal lipids.  
 
 
1.5 Methods for assessments of antioxidants 
 
 
In biological systems, the oxidation of membrane and lipoprotein lipids plays a central 
role in many pathology processes (Mattson, 2004; Poon et al., 2004a), especially in the 
context of oxidative stress-related pathologies referred to above. The aerobic organisms 
survive only in presence of oxygen, necessarily producing free radicals. Therefore, the 
antioxidant defences are extremely important in this mechanism as inhibitors of lipid 
peroxidation. The antioxidants can be synthetized in vivo or taken in from the diet. 
Similarly to the therms “oxidative damage” and “oxidative stress”, is the term 
“antioxidant” widely used but surprisingly difficult to define clearly (Halliwell and 
Gutteridge, 2007). In this context, there is also is an increasing interest in the efficacy of 
antioxidant activity of the inumerous naturally occurring molecules in food and biological 
systems, with potential to minimize oxidative damage in vivo and/or to retard the 
oxidation of easily oxidizable materials food (Lúcio et al., 2007).  
Several methods have been applied to measure antioxidant capacity of tissues, biological 
fluids or single classes of antioxidants, usually with the aim to quantify oxidative stress 
(Halliwell and Gutteridge, 2007) or protection conferred by foreign compounds.  
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Biomimetic systems 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Schematic illustration of : (A) structure of the micelles; (B) liposomes 
structure (size and lamellarity); (C) Monolayer representation.  
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The evaluation of antioxidant capacity in matrixes such as plasma, beverages, vegetables, 
and fruits as well as that of pure compounds (i.e., phenols, peptides) has become a rather 
disputable issue during the past decade. Methods and data are questioned for providing 
meaningful information to interested parties (Nenadis et al., 2007). Regardless, current 
methods are still frequently applied, providing an enormous amount of information in the 
past few years. 
Among the several available methods, they can be classified into two groups, depending on 
the reaction mechanism: methods based on hydrogen atom transfer (HAT) and methods 
based on electron transfer (ET) (Huang et al., 2005). 
The majority of HAT-based assays apply a competitive scheme (depicted schematically in 
Figure 7), in which antioxidant compound and target (representing a biomolecule which 
may be attacked in vivo) compete for the reactive species (in this work, represented by 
thermally generated peroxyl radicals through the decomposition of azo-compounds). 
Hence, the assessment of antioxidant capacity can also be divided concerning their simple 
(non-competitive) or more complex (competitive) reaction schemes, as depicted 
schematically in Figure 1.7: 
 
 
 
Reactive species Reduced reactive
species
Target
Oxidized target
Antioxidant Oxidized antioxidant
Competitive Shceme
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Figure 1.7: Schematic representation of competitive and non-competitive approaches, for 
in vitro determination of antioxidant capacity. Adapted from (Magalhães et al., 2008) 
 
 
In the competitive Scheme, the determination of antioxidant capacity relies on the 
quantification of an extra compound (probe) that facilitates the analytical measurement. 
In most of the competitive assay, the probe is the target species or its oxidized form. 
Moreover, the probe can also be a compound added after the above cited reaction that 
allows the quantification of the remaining reactive species or target molecules. Using the 
first type of strategy, the antioxidant capacity of a given compound is dependent on: (i) the 
concentration ratio of the target, probe, antioxidant and reactive species produced, (ii) the 
rate of the reaction between antioxidant compound and probe or target molecules, (iii) if 
the rate of oxidized probe is due only reactive species attack, (iv) rate of target and probe. 
On the other hand, in the non-competitive scheme, putative antioxidant compound reacts 
with the reactive species in the absence of any other competing agent. In this case, only 
two components are involved in the initial reaction mixture: the antioxidant compound 
and the reactive species. Therefore, this strategy deploys a reaction simpler than that 
applied in competitive schemes, suitable for screening assays (Magalhães et al., 2008). 
 
 
1.6. Scavenging capacity assays against specific ROS/RNS 
 
 
1.6.1 Peroxyl radical (ROO•) scavenging capacity assays 
 
 
Several methods have been proposed to address these determinations, from which the 
oxygen radical absorbance capacity (ORAC) and total radical trapping antioxidant 
parameter (TRAP) are included. Indeed, the ORAC assay is one of the most common 
Reactive species Reduced reactive
species
Antioxidant Oxidized antioxidant
Non-competitive scheme
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methods for assessing scavenging capacity against ROO• as a HAT method (Frankel and 
Meyer, 2000), developed initially by Cao, Alessio, and Cutler (1993). 
The principle of this assay is based on the intensity of fluorescence decrease of the 
target/probe along time under reproducible and constant flux of peroxyl radicals, 
generated from the thermal decomposition of AAPH in aqueous buffer (Magalhães et al., 
2008). In the presence of a sample that contains chain-breaking antioxidants, the decay of 
fluorescence is inhibited. The method measures the ability of the antioxidant in the 
sample to protect. In ORAC assay, the reaction is monitored for extended periods (≥ 30 
min) and the quantifications is based in the area under curve (AUC) that represents the 
oxidation of the probe along time. The protective effect of antioxidants is evaluated from 
the net integrated area under the fluorescence decay curves (AUCsample – AUCblank) - Figure 
1.8, and results are expressed as µM of Trolox equivalents. The advantage of the AUC 
approach is that it can be applied for antioxidants that exhibit distinct lag phases and also 
to those samples that have no lag phases. The principles of the ORAC assay can be adapted 
to determine the action against other reactive oxygen species (Ou et al., 2001). The assay 
is based on the intensity of fluorescence decrease of the target/probe along time under 
reproducible and constant flux of peroxyl radicals, generated from the thermal 
decomposition of AAPH in aqueous buffer. In the presence of a sample that contains 
chain-breaking antioxidants, the decay of fluorescence is inhibited (Glazer, 1990).  
 
Figure 1.8: Schematic representation from the net integrated area under the fluorescence 
decay curves.  
 
 
The TRAP assay was introduced by (Wayner et al., 1985), for the determination of the 
antioxidant status of human plasma. This method was based on the measurement of the 
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time period in which oxygen uptake was inhibited by plasma during a controlled ROO• 
peroxidation reaction induced by the thermal decomposition of an azo-compound. In this 
assay, the target was the human plasma while the oxygen consumed in the oxidation of 
plasma material is the probe molecule used to follow the action of antioxidants. The 
measurement is based on the “lag time” that corresponds to the time period between the 
beginning of the assay and the beginning of the oxidation of the target molecules. One of 
the major problems with the original TRAP assay lies in the utilization of the oxygen 
electrode as detector, since it may not maintain its stability over the period of time 
required (Magalhães et al., 2008). 
 
 
1.6.2 Other ROS/RNS scavenging capacity assay  
 
 
Along with peroxyl radicals, other ROS/RNS subject biological organisms to oxidative 
stress. A summarized account of current merhods for evaluation of scavenging capacity 
superoxide radical anion (O2•-), hydroxyl radical (HO•), hypochlorous acid (HOCl), 
singlet oxygen (1O2) and nitric oxide radical (NO•) is given in the following 
paragraphs. A more comprehensive account can be found elsewhere (Magalhães et al., 
2008). 
Superoxide radical anion (O2•-) is produced as a result of the donation of one electron to 
oxygen. This radical arises either from several metabolic processes or following oxygen 
activation by irradiation (Halliwell, 2006). Generally, the analytical methods for 
determination of O2•- scavenging capacity make use of the system XOD/hypoxanthine or 
xanthine at pH 7.4 to generate superoxide anion radical. 
Due to the high reactivity of hydroxyl radicals, almost anything in biological systems can 
be regarded as an HO• scavenger. Hence, this task is not performed by any specific 
molecule or enzyme. Thus, the evaluation of direct scavenging of HO• may be irrelevant for 
evaluation of antioxidant action of a compound or matrix, simply because very high 
concentrations of scavenger are required to compete with adjacent molecules in vivo or in 
the food matrix for any HO• generated. For these reason, it is more relevant and useful to 
quantify the capacity of putative antioxidants to scavenge or block the formation of its 
precursors (O2•-, H2O2, HOCl) and/or to sequester free metal ions related to HO• 
formation. Scavenger compounds that act in in this way would behave as preventive 
antioxidants. 
There are a several in vitro methodologies for determination of HO• scavenging capacity, 
including: i) absorbance increase due to reaction of thiobarbituric acid with oxidation 
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products from deoxyribose is inhibited by antioxidants; ii) formation of DMPO-OH adduct 
is measured by ESR and it is inhibited by antioxidant; iii) DHBA, formed due to oxidation 
of salicylic acid, measured using HPLC-ED and its formation is inhibited by antioxidants; 
iv) fluorescence decay along time due to oxidation of fluorescein is delayed/inhibited by 
antioxidants (ORAC method with different inducer); v) CL emission due to oxidation of 
luminal is inhibited by antioxidants (Magalhães et al., 2008). 
HOCl is generally obtained from the enzymatic system myeloperoxidase/H2O2/Cl- or by 
acidifying commercial sodium hypochloride to pH 6.2 with sulphuric acid(Aruoma, 1997).  
The former approach can be applied if the sample species do not interfere with HOCl 
generation (e.g. inhibition of myeloperoxidase activity or direct reaction with H2O2). In the 
second approach, the determination of the concentration of HOCl solution must be 
performed daily (Halliwell et al., 1995). For assessment of scavenging capacity against 
HOCl, direct spectrophotometric determination of this species along time is performed. 
Alternative methods are based on luminal-derived chemiluminescence. 
Singlet oxygen (1O2) is an excited state of molecular oxygen that has no unpaired electrons 
and it is known to be a powerful oxidizing agent, reacting directly with a wide range of 
biomolecules (Davies, 2004). Due to its decay to the lower energy ground state, 1O2 emits 
characteristic phosphorescence at 1270 nm. Therefore, the 1O2 scavenging ability of several 
compounds was measured through the decay rates of the light intensity (Tournaire et al., 
1993; Wilkinson et al., 1995). 
NO has emerged as a fundamental signaling molecule regulating virtually every critical 
cellular function, as well as a potent mediator of cellular damage in a wide range of 
conditions. Recent evidence indicates that most of the cytotoxicity attributed to NO is 
rather due to peroxynitrite -nitric oxide radical (NO•), for this reason it has indeed pivotal 
role in the regulation of diverse physiological and pathophysiological processes (Pacher et 
al., 2007). 
Vriesman et al. developed a relatively simple method for the quantification of NO• 
scavenging capacity of sulfur-containing compounds in aqueous solution using an 
amperometric NO• sensor. The assessment of NO• scavenging capacity has also been 
performed using ESR spectrometry (Asanuma et al., 2001) and fluorimetry. 
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1.6.3 Scavenging capacity assays against stable, non-biological radicals 
and evaluation of total reduction capacity 
 
 
Several methods have been reported for evaluation of total antioxidant capacity, namely 
those relying on colored radicals, 2,2’-azinobis-(3-ethylbenzothiazoline-6-sulphonate) 
radical cation (ABTS•+) and 2,2′-Azinobis-(3-ethylbenzothiazoline-6-sulphonate) radical 
cation. Other methods, relying to electron transfer, have also been successfully employed, 
including here Ferric reducing antioxidant power (FRAP assay), Folin-Ciocalteu reducing 
capacity (FC assay) and Total reducing capacity estimated by electrochemical methods. 
The TEAC assay, mediated by ABTS•+ species, involves the generation of the long-lived 
radical cation chromophore ABTS•+ which has absorption maxima at 414, 645, 734, and 
815 nm. The original TEAC assay, developed by Miller et al., was based on the activation of 
metmyoglobin, acting as peroxidase, with H2O2 to generate ferrylmyoglobin radical, which 
then reacted with ABTS to form the ABTS•+ radical cation (Miller et al., 1993). 
In this strategy, the sample to be tested is added previously to the formation of the ABTS•+ 
radicals formed and the lag phase, which corresponds to the delay time in radical 
formation, is measured (competitive scheme-Figure 7). This method has been executed 
using commercial available Kits for standardized total antioxidant status measurement in 
an individual’s serum or plasma. The disadvantage is the price and the reagent cost per 
sample estimated in the Kit-TEAC assay is approximately nine times that in the ORAC 
assay (Cao and Prior, 1998). 
In DPPH assay, the purple chromogen radical 2,2-diphenyl-1-picrylhydrazyl radical 
(DPPH•) is reduced by antioxidant/reducing compounds to the corresponding pale yellow 
hydrazine (Magalhães et al., 2008). The scavenging capacity is generally evaluated in 
organic media by monitoring the absorbance decrease at 515-528 nm until the absorbance 
remains constant (Magalhães et al., 2008) or by electron spin resonance (Calliste et al., 
2001). 
The FRAP assay measures the ability of antioxidants to reduce the ferric 2,4,6-tripyridyl-s-
triazine complex [Fe(III)-(TPTZ)2]3+ to the intensely blue coloured ferrous complex 
[Fe(II)-(TPTZ)2]2+ in acidic medium (Benzie and Strain, 1996; 1999). This method has also 
been adapted to 96-well microplate reader, giving better reproducibility and higher 
sample throughput (Tsao et al., 2003). 
The exact chemical nature of the Folin-Ciocalteu reagent is not known, but it is accepted 
that is contains phosphomolybdic/phosphotungstic acid complexes (Singleton and Rossi, 
1965). The chemistry behind the FC assay relies on the transfer of electrons in alkaline 
medium from phenolic compounds and other reducing species to molybdenum, forming 
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blue complexes that can be detected spectrophotometrically at 750-765 nm (Singleton et 
al., 1999).  
Finally, the electrochemical properties of pure compounds, foods, and biological samples 
may be used for the evaluation to their reducing/antioxidant capacity, since the electric 
oxidation potential has conceptually relation with the expected antioxidant capacity. This 
determination has been frequently automated using flow injection analysis schemes 
(Magalhães et al., 2009). 
 
 
1.7 Methods for antioxidants assessment with biomimetic structures 
 
 
A schematic representation of all factors, including physical and chemical features, are 
depicted in Figure 1.8. It is important to highlight that a major concern in these studies 
should be the effect of antioxidants depends on both the composition, physical properties 
and structure (LUV, MLV, SUV, etc) of the liposomal system chosen and the inducer. 
 
 
 
Figure 1.9: Physical and chemical factors that affect the peroxidation of liposomal lipids. 
Adapted from (Schnitzer et al., 2007b) 
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In order to illustrate the different conditions used for oxidation/antioxidant evaluation 
with biomimetic structures, Tables 1.3 to 1.6 are presented, where a summary lipid, 
preparation method, oxidation initiator, principle of measurement of detection system, 
calibrator, data treatment, applications, references for each method given. Selected 
aspects of these methodologies are discussed in the following sections. 
 
 
1.7.1 Type of biomimetic systems 
 
 
In studies of lipid peroxidation the biomimetic structures of the biological systems, used 
were essencially micelles, MLVs, LUVs and SUVs, comprising structures with different 
lipid composition, size, lamellarity, stability and preparation protocol, whose 
nomenclature was defined in the 1980s.  
As discussed before, liposomes are classified by their lamellarity and size range (Figure 5). 
Both these aspects are relevant towards lipid peroxidation for at least two reasons: i) they 
constitute a simple and convenient system where the oxidation process can be reproduced 
with different levels of complexity and ii) liposomes are currently being used for 
diagnostic and therapeutic purposes and lipid oxidation may impair their stability. 
Concerning their complexity features, all structures being about advantages and 
disadvantages. For instance, the MLVs have a more simpler preparation comparatively for 
LUVs and SUVs, but the interpretation of results may not be so easy because the structure 
is not well defined, with several lipidic layers. 
Therefore, when using MLVs in the presence of inducers of oxidation the outer monolayer 
is more to oxidative attack, but the layer inside are not accessible. 
Hence, unilamellar liposomes seem to be a more suitable model for studding the free 
radical oxidation that take place in vivo, because biomembranes, in general, consist of 
unilamellar structures. The LUVs have a more resemblance with the biological membrane 
structure but studies as those performed by Barclay et al (1987) demonstrated that the 
oxidizability of PC in unilammelar liposomes was higher than that in multilamellar 
liposomes, because of the different packing of the lipid chain in LUV compared to that in 
MLV. Furthermore, despite the more complex LUV preparation its size is well defined. 
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1.7.2 Lipids employed 
 
 
The lipids more used in biomimetic systems preparation are egg phosphatidylcholine and 
soybean phosphatidylcholine, however other lipids are used in biomimetic systems 
preparation, such as: 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-
dilauroyl-sn-glycero-3-phosphocholine (DLPC), 1,2-dioctadecanoyl-sn-glycero-3-
phosphocholine (DSPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 
dioleoylphosphatidylcholine (POPC), 1-stearoyl-2-linoleoylsn-glyceryl-3-phosphocholine 
(SLPC) and linoleic acid. 
The EPC is an phosphoslipid containing choline, also named as lecithin. It is the most 
abundant phospholipid in nature and the most frequently used in biomimetic strutures 
preparation. Indeed, it is ideal for use in studies as model biological membranes because it 
is a natural lipid found in these membranes. The lecithin can be extracted from the egg 
yolk or soybean, comprising a lipid mixture, with carbonyl chains bearing different lengths 
and different degrees of unsaturation. Typical lots of egg yolk phosphatidylcholine have 
fatty acid contents of approximately 33% 16:0 (palmitic, the most abundant in lecithin), 
13% 18:0 (stearic), 31% 18:1 (oleic), and 15% 18:2 (linoleic), with other fatty acids being 
minor contributors, givening an average molecular weight of approximately 768. The 
liposomes from lecithin are zwitterionic, therefore, with neutral charge at physiologic pH. 
The main drawback of the application of natural lipids is in its complex composition, with 
consequences for interpretation of results.  
DPPC is a semi-synthetic lipid, which can be easily characterized to concerning its phase 
transition, among other thermodynamic parameters comparatively to natural lipids.  
The multilamellar vesicles are prepared by hydration of a lipid film, as referred previously, 
through an easy and fast method.  
The hydration lipid film is a common step in MLVs, LUVs and SUVs preparation because 
the amphiphilic phospholipids, bearing a hydrophilic group, do not aggregate in micelles, 
when in aqueous solution, because instead, due to their large structure, they form vesicles, 
from bilayers that fold, forming closed spherical structures. 
In the several examples taken from literature (Table 1.3) Unilamellar vesicles were formed 
from different mechanical agitation processes, starting from the suspension formed after 
lipid film hydration. Hence, for LUVs preparation, several techniques were employed 
namely: De-Rehydration, extrusion, detergente dialisys, reverse evaporation and freeze-
thaw cycling. The technique most used is undoubtedly the extrusion because despite being 
slow and complex, it leads to the formation of the homogeneous structures with well 
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defined size range, with good stability and very similar to biological structures concerning 
their bilayer structure. 
The SUVs preparation is possible through different techniques: sonication, extrusion, 
high-pressure homogenization and solvent injection. The first is the technique most used, 
but references found in the literature do not mention details about the amplitude, 
numbers of cycle for sonication in order to obtain structures with size ≤ 100 µm. 
For preparation micelles a surfactant is used, because these types of molecules have a 
capacity to form aggregates in aqueous media. The interface area between the 
hydrocarbon chains of the surfactant and water decrease, consequently the monomers are 
associated and form aggregates. The polar head is in contact with the aqueous media and 
hydrophobic tail bears inside the micelle structure. Therefore, the micelles are prepared 
simply by dispersion in aqueous media. 
 
EPC 
 
DPPC 
 
 
 
HePC 
Figure 1.10: Structure of lipid used in different works. For R1, R2 composition please see 
text.  
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1.7.3 Initiator of oxidation 
 
 
In many reports, the lipid peroxidation is induced by various biologically relevant inducers 
(e.g. transition metals and enzymes), from which the most commonly inducers are copper 
and iron ions (commonly applied in the presence of ascorbic acid). Moreover, synthetic 
radical generators are also often applied. Some of them are water-soluble (e.g. 
ABAP/AAPH) and others are lipid-soluble (e.g. AMVN) (Schnitzer et al., 2007b). 
In fact AAPH is a water soluble azo compound which has been extensively as a free radical 
generator. In this case the free radicals are formed in solution and attack the external part 
of liposomes. The decomposition of AAPH produces molecular nitrogen and two carbon 
radicals. The carbon radicals may combine to produce stable products or react with 
molecular oxygen to give peroxyl radicals. 
 
 
 
 
 
 AAPH AMVN 
 2,2′-azobis(2-amidinopropane) dihydrochloride 2,2′-azobis(2,4-dimethylvaleronitrile) 
 
Figure 1.11. Molecular structure of thermolabile azo-compounds used for generation of 
peroxyl radicals. 
 
 
1.7.4 Measurement of oxidation 
 
 
The measurement of oxidation extent can be performed directly, by measuring the 
products of oxidation or oxygen consumption, or indirectly, using fluorescent probes that 
are also prone to oxidation. 
Malondialdehyde, arising from peroxidation of PUFAs with more them two double bonds 
(such as linoleic and arachidonic acids), is frequently determined by the Thiobarbituric 
N N CH3
CH3NH2
NH
CH3
CH3
NH
NH2
HCl
HCl CH3 N N
NCH3 CH3
CH3
CH3
CH3
N
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acid method. This method, also called TBARS (from thiobarbituric acid reactive 
substances), to generates a coloured product, a (TBA)2-MDA adduct, measured 
spectrophotometrically. However, the application of this method has been disputed 
(Halliwell and Gutteridge, 2007) because other TBARS are formed along the 
quantification, biasing the final results. 
Other common method of analysis, consist on the measurement of intermediates, namely 
conjugates dienes. The oxidation of PUFAs forms conjugated dienes that absorb UV light 
at 230 to 235 nm. Measurement of dienes is a useful index of peroxidation in pure lipids 
and isolated lipoprotein and has the advantage that it measures an early stage in 
peroxidation (Halliwell and Gutteridge, 2007). Diene conjugates measurements can rarely 
be carried out directly on tissues and body fluids because many others substances present 
absorb strongly in the UV. Extraction of lipids into organic solvents (e.g 
chloroform:methanol mixture) before measurement is a common approach to this 
problem. 
Finally, measurement of peroxides as end-products of lipid peroxidation has also been 
carried out, using high performance liquid chromatography or gas chromatography. This 
approach allows the determination of different reaction products, as they are separated in 
the chromatographic colunn. 
Several membrane-partioning probes, as indirect reports of oxidation, have been 
introduced to measure lipid peroxidation or reactive species within membranes: 1,6-
Diphenyl-1,3,5-Hexatriene, diphenylhexatriene propionic acid, trimethylamine-
diphenylhexatriene and another popular probe is C11 Bodipy 581/591 (upon oxidation, its 
fluorescence shifts from red to green, so that the green/(red+green) ratio can be used as 
an estimate of membrane oxidation.  
 
 
1.7.5 Applications 
 
Application towards aromatic plants, various medicinal and culinary herbs, food products 
were frequent. Some endemic species are of particular interest for small countries as 
products with important role as antioxidant. Plant extracts, rich in polyphenols and 
bioactive compounds, have also been tested. 
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2. Material and Methods 
 
 
2.1. Introduction 
 
 
In this chapter, reagents and general steps for preparation of solutions that were used 
throughout this work are described. Furthermore, several aspects related to the ORAC 
methodology for evaluation of antioxidant capacity of various compounds, the 
comparative study among of biomimetic lipid aggregates (micelles and vesicles) as in vitro 
models to assess antioxidant capacity against peroxidation, dynamic light scattering (DLS) 
characterization of the structures used, microplate fluorimetric methodologies to assess 
antioxidant activity at different locations (hydrophilic medium, interface and lipophilic 
medium) on phospholipid membranes with optimization procedures and the expression of 
this parameters and the study of antioxidants (biological and reference) effect at air-water 
interface for biophysical approach to membrane peroxidation. 
 
 
2.2. Reagents, solutions and samples 
 
 
All chemicals used were of analytical reagent grade with no further purification, purchased 
from several suppliers and stored according to the product information. For the 
preparation of all solutions, water from Milli-Q system (resistivity > 18 MΩ cm), ethanol, 
methanol and chloroform pro analysis were used throughout the work. 
Standard stock solutions were obtained by rigorous weighing the respective reagent in a 
Mettler Toledo analytical balance (model AG 285), followed by dissolution in the 
appropriate solvent (namely water, buffer solution, ethanol, methanol, chloroform, or 
combinations of these liquids). 
The working standards were obtained by rigorous dilution of the stock solution using 
Gilson micropipettes with disposable tips, volumetric flasks (class A) of different volumes. 
Micropipettes (models P100, P200, P1000, and P5000, with corresponding maximum 
capacities of 100, 200, 1000, and 5000 µL) were regularly calibrated with deionised water. 
  
Chapter 2: Materials and methods 
 
62 
 
Whenever necessary, pH of solutions was measured using a pH-meter GLP-21 equipped 
with a combined reference-glass pH electrode (Crison 52-02), namely the phosphate 
buffer at pH 7.4. 
The phosphate buffer volume was heated to 37ºC before the dissolution of the AAPH, 
allowing the formation of radicals generation in the work described in Chapters 3 and 4.  
In all experiments, aqueous/buffer solutions were prepared for water soluble compounds. 
For compounds that are sparingly soluble in water, solutions containing up to 50% of 
ethanol (or chloroform:methanol (3:1)) were prepared. For compounds, including 
antioxidants and fluorimetric probes, with low/very low solubility in water, prior 
incorporation into the biomimetic structures was performed by dissolving the compound 
in the organic solvent containing the lipids for monolayer or vesicle preparation. 
 
 
2.3. Fluorimetric measurements 
 
 
In this thesis, the ORAC method(Ou et al., 2001) was used in the presence of biomimetic 
lipid structures. The ORAC method consists on the generation of peroxyl radicals in the 
presence of a probe, fluorescein, that upon oxidation has its fluorescence quenched. The 
presence of antioxidants removes peroxyl radicals from the reaction media, avoiding or 
delaying the oxidation of the probe. This assay was performed using a microplate reader 
(MR), model Synergy HT, from Bio-Tek Instruments Inc. (Winooski, VT, USA). This MR 
allowed fluorescence, absorbance and luminescence measurements. In this work the 
fluorimetric measurements were performed using a tungsten halogen lamp with 
interference filters for wavelength specificity, λexc=485±20; λexc=528±20 and λexc=360±40; 
λexc=460±40 in conjunction with a photomultiplier tube. The tungsten halogen lamp 
produces a large amount of light at a constant intensity, providing increased sensitivity 
and repeatability. Moreover, specially designed fluorescent interference filters prevent 
light leakage from excitation wavelength to the emission wavelength, particularly 
important with fluorescent compounds with small Stoke's shifts. Disposable 96-wells 
microplates were obtained from Orange Scientific. 
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2.4. ORAC method – quantification 
 
 
The quantification of antioxidant capacity in the ORAC method is based on the area under 
the curve (AUC, depicted in Figure 8) that represents the oxidation of the probe along 
time. The protective effect of antioxidants is evaluated from the net integrated area under 
the fluorescence decay curves (AUCsample – AUCblank) and results are generally expressed as 
µM of trolox equivalents (Equation 1). The advantage of the AUC approach is that it can be 
applied for antioxidants that exhibit distinct lag phases and also to those samples that 
have no lag phases. Moreover, it takes into account the initial reaction rate and the total 
extent of probe attack, which includes the action of slow-reacting or secondary antioxidant 
products formed. 
 
[(AUCsample – AUCBlank)/(AUCTrolox – AUCBlank)] × [(moles of Trolox/moles of sample)] 
 
Equation 1. 
 
 
All experiments were carried out in triplicate and using some wells for different control 
experiments (microplate self-fluorescence, probe alone, with and without radicals 
generator or antioxidant) for all assays. The reactions were performed at 37ºC as the 
reaction was started by thermal decomposition of AAPH in 75 mM phosphate buffer, pH 
7.4. Data acquisition was performed by Gen 5 software, with data stored as readings of 
fluorescence intensity for every minute during total time periods between 30 min and 
three hours. 
 
 
2.5. Preparation of biomimetic lipid systems 
 
 
Various models of biomembranes, including 2D (monolayers) and 3D (micelles and 
vesicles) were selected for the studies performed in this thesis. The steps required for their 
preparation are schematically depicted in Figure 1. 
The hexadecylphosphocholine (HePC) micelles were prepared in a round flask, for 
addition of the surfactant, in 75 mM phosphate buffer, pH 7.4 at 2.304 mM, then the 
solution was vortexed during 10 minutes, followed by 2-3 passages through filters with 
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pore size of 100 µm, placed on an extruder. The classical methodology for micelles 
preparation described in the literature(Menez et al., 2007) was modified, because with the 
previous procedure did not fostered the production of micelles with size characteristic - 
6.79/181.0±2.2   
For MLV preparation, the lipid (EPC in generally) is dissolved in chloroform:methanol 
(3:1) in round-bottomed flask, later the solvent was removed under reduced pressure on a 
rotary evaporator with the water bath set at 30ºC. N2 is introduced to re-establish 
atmospheric pressure and the flask was covered in aluminum foil to avoid lipid oxidation. 
A pump is then used to keep the flask under a pressure of ˂ 0.5 mmHg during at least 1 h. 
After solvent evaporation, the resulting lipidic film was hydrated with a given volume of 
phosphate buffer (75 mM, pH = 7.4) and vortexed during 10-15 minutes. The final 
preparation was a whitish homogeneous liquid. 
For preparation of LUVs, this suspension was submitted to extrusion, comprising two 
passages through a polycarbonate filter with a pore size of 200 µm, followed by ten 
passages through a filter with pore size of 100 µm into extruder. 
For SUVs preparation, the suspension containing MLVs was sonicated with a sonication 
probe (Sonics Vibracell model CV18), during 20 cycles of 1 minute each, with an amplitude 
of 85%. The preparation was performed with attention of the lipid volume, because with 
sonication of volume larger of lipid solutions not possible obtainer the solution with 
uniform size vesicles. 
 
 
Figure 2.1: Schematic representation of techniques used in this work for preparation of 
biomimetic systems.  
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The characterization of the micelles and vesicles used in this thesis was performed in a BI-
MAS DLS instrument (Brookhaven Instruments, USA) containing a controlled 
temperature cell holder - Dynamic Light Scattering Instrument.  
The samples were placed in a quartz cuvette at 37ºC (the same temperature applied for all 
assays) for measurement of the mean size, the size distribution of particles, and a potential 
zeta. 
 
 
2.6. Surface pressure – area measurements in monolayers 
 
 
Langmuir monolayers at the liquid-air interface are well-defined interfacial systems and, 
therefore, excellent model systems to give information about the lipid phases and the 
phase transitions, which are both dependent on the temperature, the pressure, and the pH 
(Nunes et al., 2011; Wustneck et al., 2005). The surface pressure-area (pi/A) isotherms 
(depicted in Figure 2) give information about the phases, the type of phase transition (first 
or second) of a lipid monolayer, the minimum area per molecule and the compressibility. 
The minimum area per molecule (Amin) is the mean area occupied for one molecule in the 
surface layer and it indicates the molecular packing and the interactions between the 
monolayer components. This parameter was determined by extrapolation from the 
isotherm. Elastic modulus (Cs-1) was calculated from the pi/A isotherms by the following 
equation: 
Cs-1 = -A (dpi/dA),  
where A is the area per lipid molecule, and pi is the surface pressure. Cs-1 describes the 
relationship between the surface pressure increase and the area per molecule decrease. A 
higher value of Cs-1 is indicative of a less compressible monolayer (Nunes et al., 2011; Wang 
and Yang, 2009). 
The lipid DPPC, DPPC+α-linolenic acid, EPC were prepared for dissolution in Chloroform. 
The spreading solutions were deposited onto the aqueous subphase with a Hamilton 
microsyringe, precise to 2.0 µL. After spreading, the monolayers were left to equilibrate 
for ca. 10 min for solvent evaporation prior to film compression (barrier speed of 20 cm2 
min-1).  
The π–A isotherms of DPPC, DPPC+α-linolenic acid and EPC, expressed for the absolute 
molecular area (Å2 per molecule) of DPPC or of EPC, were recorded with a NIMA 601 
(Nima Technology, Coventry, UK) Langmuir trough (total area = 600 cm2; subphase 
volume c.a. 400 mL).  
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The concentration of the lipid simple or mixture surface pressure was measured, before 
beginning compression, with the accuracy of ± 0.1 mN m-1 using a Wilhelmy type 
dynamometric system with a strip of filter paper. All measurements were performed at 21 
°C (controlled room temperature). Π–A isotherms were measured at least twice to 
collapse monolayer. Before each measurement, the trough was cleaned thoroughly with 
chloroform and double deionized water. 
Parameters pertaining to each isotherm (elastic modulus Cs-1, πcollapse, Acollapse, Amin) were 
assessed.  
 
 
 
Figure 2.2: Isotherm representation, of DPPC monolayer obtained with a NIMA 601 
(Nima Technology, Coventry, UK) Langmuir trough (total area = 600 cm2; subphase 
volume c.a. 400 mL of the phosphate buffer) and BAM images at different pressures and 
lipid phases (LE-lipid expanded; LE/LC-lipid expanded/lipid condensed; LC – lipid 
condensed and monolayer collapse). 
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2.7 Brewster angle microscopy (BAM) in monolayers 
 
 
Brewster angle microscopy (BAM) is a powerful tool that enables the visualization of the 
morphological changes (depicted in Figure 2): beginning of domains formation, domains 
shape in different phases (LE and LC), domains shape disappearance and collapse that 
occur during the compression of the monolayers. Moreover, BAM also gives some 
information on the fluidity of the film in relation to the geometry of the domains observed 
at the water interface (Allouche et al., 2007). The contrast in BAM images is due to local 
differences in the monolayer refractivity index, caused by differences in local molecular 
density or packing (Alonso et al., 2004; Bringezu et al., 2002; Goncalves da Silva and 
Romao, 2005).  
Brewster angle microscopy (BAM) images were obtained from a I-Elli 2000 apparatus 
(supplied by Nanofilm Technologies, Gӧttingen, Germany) using a Nd:YAG diode laser, 
which were recorded with a lateral resolution of 2 µm. The image processing procedure 
included a geometrical correction of the image, as well as a filtering operation to reduce 
interference fringes and noise. Furthermore, the brightness of each image was scaled to 
improve contrast. The size of the images is 430 µm in width. The microscope and film 
balance were located on a table with vibration isolation (antivibration system MOD-2 S, 
Halcyonics, Göttingen, Germany) in a large class 100 clean room.  
BAM images were obtained from the π± 0.1 mN m-1 (before compression) to monolayer 
collapse (variable with different assay conditions) for monitoring different aspects: 
namely, the initial images, beginning of domains formation, domains shape in different 
phases (LE and LC), domains shape disappearance and collapse.  
 
 
2.8 References 
 
 
Allouche, M.; Castano, S.; Colin, D.; Desbat, B.; Kerfelec, B. Structure and orientation of 
pancreatic colipase in a lipid environment: PM-IRRAS and Brewster angle microscopy 
studies. Biochemistry 2007, 46, 15188-97. 
Alonso, C.; Alig, T.; Yoon, J.; Bringezu, F.; Warriner, H.; Zasadzinski, J. A. More than a 
monolayer: relating lung surfactant structure and mechanics to composition. Biophys J 
2004, 87, 4188-202. 
Chapter 2: Materials and methods 
 
68 
 
Bringezu, F.; Ding, J.; Brezesinski, G.; Waring, A. J.; Zasadzinski, J. A. Influence of 
Pulmonary Surfactant Protein B on Model Lung Surfactant Monolayers. Langmuir 2002, 
18, 2319-2325. 
Goncalves da Silva, A. M.; Romao, R. I. Mixed monolayers involving DPPC, DODAB and 
oleic acid and their interaction with nicotinic acid at the air-water interface. Chem Phys 
Lipids 2005, 137, 62-76. 
Menez, C.; Legrand, P.; Rosilio, V.; Lesieur, S.; Barratt, G. Physicochemical 
characterization of molecular assemblies of miltefosine and amphotericin B. Molecular 
pharmaceutics 2007, 4, 281-288. 
Nunes, C.; Brezesinski, G.; Pereira-Leite, C.; Lima, J. L.; Reis, S.; Lucio, M. NSAIDs 
interactions with membranes: a biophysical approach. Langmuir 2011, 27, 10847-58. 
Ou, B. X.; Hampsch-Woodill, M.; Prior, R. L. Development and validation of an improved 
oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. 
Journal of Agricultural and Food Chemistry 2001, 49, 4619-4626. 
Wang, Z.; Yang, S. Effects of fullerenes on phospholipid membranes: a langmuir 
monolayer study. Chemphyschem 2009, 10, 2284-9. 
Wustneck, R.; Perez-Gil, J.; Wustneck, N.; Cruz, A.; Fainerman, V. B.; Pison, U. Interfacial 
properties of pulmonary surfactant layers. Adv Colloid Interface Sci 2005, 117, 33-58. 
 
 
  
 
 
 
 
 
 
  
CHAPTER 3 
Insights about α-tocopherol and Trolox 
interaction with phosphatidylcholine 
monolayers under peroxidation conditions 
through Brewster Angle Microscopy 
 
 
Chapter 3 
 
70 
 
3.Insights about α-tocopherol and Trolox interaction with 
phosphatidylcholine monolayers under peroxidation conditions 
through Brewster Angle Microscopy 
 
 
3.1 Introduction 
 
 
Biological membranes are not only a remarkable barrier to keep the cell intact, but they 
also allow exchange of substances required for or produced from the cell metabolism 
(Edidin, 2003). The membranes are centrally involved in the control and execution of a 
great variety of cellular processes, thus requiring the maintenance of their proper 
structure and function (Mueller et al., 2012; Nugent and Jones, 2012). Hence, any 
perturbation of the bilayer structure may lead to modifications of membrane properties 
and, consequently, changes on its physiological role. Phospholipids are the main 
components of the biological membranes, liable to free radical attack that induces lipid 
peroxidation. This uncontrolled oxidative reaction generates cytotoxic compounds and 
disrupts the various important structural and protective functions associated with 
biomembranes, and it has been implicated in the etiology of many diseases, including 
cancer, cardiovascular and neurological diseases, and other oxidative stress mediated 
dysfunctions (Halliwell and Gutteridge, 2007). 
In fact, several biophysical changes and associated kinetic features have been identified on 
membrane models under peroxidation conditions through either experimental or 
theoretical approaches. For instance, peroxidation of liposomes was shown to be faster 
when the oxidizable lipids reside in the relatively rigid gel phase bilayers than in the less 
tightly-packed liquid crystalline bilayers(Cubillos et al., 2006; McLean and Hagaman, 
1992; Mowri et al., 1984). Moreover, exposure of liposomes comprising 
dilinoleoylphosphatidylcholine (DLPC) and cholesterol to conditions of spontaneous 
oxidation caused the formation of moderate levels of hydroperoxides and a concentration-
dependent formation of discrete immiscible cholesterol-rich domains, as observed by 
small angle X-ray scattering (SAXS) (Jacob and Mason, 2005). This technique also 
allowed the observation of a marked reduction of the width of the hydrocarbon core, a 
similar decrease of the overall width of the membrane, and a decrease of the molecular 
volume of the bilayers as a consequence of iron(II)/ascorbate-induced peroxidation of 
liposomal DLPC (Mason et al., 1997). Theoretical molecular dynamics simulations led to 
similar conclusions concerning the changes on organized lipid structures (Cwiklik and 
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Jungwirth, 2010; Khabiri et al., 2012; Leekumjorn et al., 2009; Wong-Ekkabut et al., 
2007). 
The deleterious consequences of membranes peroxidation have stimulated numerous 
studies on the efficacy and mechanisms of action of biologically relevant antioxidants 
(Cuzzocrea et al., 2001; KamalEldin and Appelqvist, 1996; Niki, 1987; Valko et al., 2007; 
Valko et al., 2006). Lipidic biomimetic models, namely large unilamellar vesicles (LUVs), 
have been applied to assessment of antioxidant activity of compounds upon peroxidation 
conditions(Lúcio et al., 2009; Reis et al., 2010; Schnitzer et al., 2007; Tsuchiya et al., 
2010). Langmuir monolayers formed by phosphatidylcholines bearing different acyl 
chains, with and without unsaturations, have also been applied for studying of rosmarinic 
acid interaction with this biomimetic model, showing that cholesterol decreases the 
penetration of rosmarinic acid (Fadel et al., 2011). More recently, by using Brewster angle 
microscopy (BAM) and Langmuir monolayer compression isotherms, the presence of an 
oxidatively modified phosphatidylcholine in monolayers was shown to efficiently oppose 
the miscibility transition and to stabilize micron-sized domain separation at lipid lateral 
packing densities corresponding to the equilibrium lateral pressure of c.a. 32 mN m-1 that 
is suggested to prevail in bilayer membranes (Volinsky et al., 2012). Despite these 
examples, information about mechanistic details, especially those concerning the role of 
interactions between antioxidant compounds and membranes, are still to be unveiled. 
Hence, the objective of the present work is to evaluate the interaction between 
antioxidants and the organized monolayer formed by phosphatidylcholine molecules at 
air/water interface upon peroxidation conditions. For this, a biophysical approach will be 
implemented, by profiling the changes of surface pressure (π) and molecular area (A) 
upon monolayer compression and by monitoring monolayer features and domain 
formation through BAM. Peroxidation conditions will be fostered by the presence of 
peroxyl radicals generated by previous thermal decomposition of 2,2'-azobis(2-
methylpropionamidine) dihydrochloride (AAPH) in the aqueous buffered subphase. The 
role of α-tocopherol, a relevant natural antioxidant, and of its water soluble analogue 
Trolox will be assessed through modifications in the π-A isotherms profile and changes on 
formation of lipid domains obtained by BAM. 
 
 
3.2 Reagents and solutions 
 
 
Egg yolk L-α-phosphatidylcholine (EPC), potassium phosphate monobasic, 2,2'-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), α-linolenic acid (LA), and α-tocopherol 
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were purchased from Sigma-Aldrich (St. Louis, MO). 1,2-dihexadecanoyl-sn-glycero-3-
phosphocholine (DPPC) was purchased from Avanti Polar Lipids Inc. 6-Hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid (Trolox) was obtained from Fluka (Buchs, 
Switzerland). Chloroform from Landilab (Porto, Portugal) was used as co-spreading 
solvent. The subphase used, 75 mM hydrogen phosphate/phosphate buffer (pH 7.4), was 
prepared using Milli-Q water (resistivity > 18.2 MΩ cm, Millipore, Billerica, MA). 
Lipid solutions were prepared in chloroform and they contained DPPC (0.734 mg mL-1), 
DPPC + LA (9:1, w/w; 0.642 mg mL-1 of DPPC) or EPC (0.751 mg mL-1). Trolox was added 
to the subphase buffer at 20 µM. For generation of peroxyl radicals, AAPH (12 mM) was 
dissolved in hydrogen phosphate buffer at 37 °C and kept at this temperature during 10 
minutes. Whenever necessary, Trolox was dissolved in this solution immediately before it 
was poured into the trough. α-Tocopherol (20 µM) was incorporated onto lipid solutions 
prior to monolayer spreading. 
 
 
3.3 Results 
 
 
3.3.1 π-A measurements 
 
 
The isotherm obtained for DPPC spread on aqueous phosphate buffer pH 7.4 (Fig. 3.1) 
presents the characteristic shape reported before(Duncan and Larson, 2008) for other 
subphases, with a marked plateau between 63 to 80 Å2 per molecule at surface pressure of 
ca. 6-7 mN m-1, corresponding to the transition of expanded liquid (LE) to condensed 
liquid (LC). Other parameters, including Amin (57 Å), πcollapse (53 ± 1 mN m-1), Acollapse (47.1 
± 1.0 Å) and the elastic modulus Cs-1 (248 mN m-1) are also in agreement with values 
described in the literature (Duncan and Larson, 2008; Nunes et al., 2011). (Table 3.1). 
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Table 3.1. Characteristic parameters (elastic modulus, collapse pressure and collapse area) 
of the Langmuir monolayers tested on aqueous subphases containing the peroxidation 
inducer (AAPH) and antioxidants (Trolox and α-tocopherol) 
 
Lipid system Subphase Cs-1 
(mN m-1) 
πcollapse 
(mN m-1) 
Acollapse 
(Å per molecule) 
DPPC Phosphate buffer pH 7.4 248 53 ± 1 47.1 ± 1.0 
 AAPH 142 62 ± 1 33.6 ± 0.3 
 Trolox 450 60 ± 2 34.4 ± 2.5 
 Trolox + AAPH 145 63 ± 1 32.9 ± 1.3 
 α-tocopherol 195 59 ± 1 34.9 ± 1.9 
 α-tocopherol + AAPH 110 64 ± 1 27.3 ± 0.3 
DPPC + LA Phosphate buffer pH 7.4 117 49 ± 1 47.8 ± 1.1 
 AAPH 160 63 ± 1 34.7 ± 1.3 
 Trolox 216 60 ± 1 37.8 ± 1.3 
 Trolox + AAPH 159 64 ± 1 29.5 ± 0.3 
 α-tocopherol 152 51 ± 1 50.5 ± 1.1 
 α-tocopherol + AAPH 175 59 ± 1 27.2 ± 0.7 
EPC Phosphate buffer pH 7.4 93.3 42 ± 1 46.1 ± 2.8 
 AAPH 96.3 45 ± 1 46.1 ± 1.1 
 Trolox 95.2 44 ± 1 59.6 ± 1.7 
 Trolox + AAPH 103 45 ± 1 61.8 ± 3.4 
 α-tocopherol 108 45 ± 1 50.4 ± 2.4 
 α-tocopherol + AAPH 133 43 ± 1 62.6 ± 1.6 
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The addition of linolenic acid to the DPPC monolayer caused a decrease in the elastic 
modulus Cs-1 (117 mN m-1) and in the πcollapse (49 ± 1 mN m-1). At the same time, Acollapse 
(47.8 ± 1.1 Å) was the same, but Amin increased to 79 Å. Furthermore, the plateau 
corresponding to LE/LC phase transition observed for the DPPC disappeared when 
linolenic acid was present (Fig. 1). 
 
 
Figure 3.1. Surface pressure-area isotherms of monolayers formed by DPPC (■), DPPC + 
LA (●) and EPC (▲) upon a phosphate buffer (pH 7.4) subphase. 
 
For EPC, no plateau corresponding to LE-LC phase transition was observed (Fig. 3.1). 
πcollapse (42 ± 1 mN m-1) and the elastic modulus Cs-1 (93.3 mN m-1) were lower than the 
values obtained for DPPC monolayers (Table 1). Moreover, Acollapse (46.1 ± 2.8 Å) was not 
significantly different, and Amin was further increased to 97 Å. These observations are in 
agreement with EPC isotherms given in the literature.(Mitsche et al., 2010; Rigoletto et al., 
2011) 
The addition of AAPH to the subphase or the incorporation of α-tocopherol did not cause 
significant changes in the shape of DPPC isotherm but an increase of πcollapse (c.a. 60 mN 
m-1) and a decrease of Acollapse (c.a. 34 Å) were observed. These changes were also observed 
for DPPC isotherms obtained for other subphases (Fig. 3.2 and 3.3, A), with a concomitant 
shift of the isotherm towards higher values of area per molecule. This shift was more 
pronounced for monolayers tested with α-tocopherol + AAPH, followed by Trolox + 
AAPH. 
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Figure 3.2. Surface pressure-area isotherms for different lipid systems, with monolayers 
formed and compressed above subphases containing phosphate buffer pH 7.4 (■), AAPH 
solution (●), Trolox solution (▲) and AAPH + Trolox solution (▼). A: DPPC; B: DPPC + 
LA; C: EPC.  
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Figure 3.3. Surface pressure-area isotherms for lipid systems containing α-tocopherol, 
with monolayers formed and compressed above subphases containing phosphate buffer 
pH 7.4 (without α-tocopherol: ■; with α-tocopherol: ▲) or AAPH solution (without α-
tocopherol: ●; with α-tocopherol: ▼). A: DPPC ; B: DPPC + LA; C: EPC.  
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For DPPC + LA monolayer (Fig. 3.2 and 3.3, B), the addition of AAPH to the subphase 
restored the plateau corresponding to the LE/LC phase transition and this was shifted 
towards higher areas per DPPC molecule when compared to the DPPC isotherm. In fact, 
this behavior was observed for all DPPC + LA monolayers containing either the 
antioxidants or their combination with AAPH in the subphase. 
When the antioxidants (α-tocopherol or Trolox) were present with AAPH, a decrease of 
Acollapse was also observed (from 47 to 28 Å) for both DPPC and DPPC + LA monolayers. 
This observation was accompanied by a less steep increase of surface pressure for values 
above 53 mN m-1 (which corresponds to πcollapse of monolayers spread over phosphate 
buffer). 
For EPC, the addition of AAPH provided πcollapse and Acollapse similar to those obtained for 
the phosphate buffer subphase, but a slight displacement of the whole isotherm towards 
lower molecular areas (c.a. –10 Å2 per molecule) was observed (Fig. 3.2 and 3.3, C). This 
displacement was further exaggerated when Trolox was present in the subphase (c.a. –20 
Å2 per molecule at 10 mN m-1) or when α-tocopherol was incorporated to the monolayer 
(c.a. –30 Å2 per molecule). However, when both AAPH and antioxidants were present, the 
isotherm was shifted to the opposite direction towards larger areas per molecule (c.a. + 10 
to 15 Å2 per molecule). 
 
 
3.3.2 BAM observation 
 
 
The morphology of all monolayers was directly visualized by BAM simultaneously to the 
π−A isotherm recording. Light gray structures appeared upon compression of the DPPC 
monolayer spread over a phosphate buffer subphase (Fig. 3.4B) and they became 
organized into bean and two-lobed shaped domains against a black matrix at 6.3 mN m-1 
(Fig. 3.4C); these structures evolved to more complex multilobed domains (Fig. 3.4D) 
within a small change of surface pressure, corresponding to LE/LC transition (Klopfer and 
Vanderlick, 1996). Up to 10 mN m-1, the domains became larger, occupying a larger area 
than the dark background. The light gray domains became less organized with smoother 
contours as soon as the surface pressure increases above 10 mN m-1 (Fig. 3.4E and 3.4F) 
and the observation area was completely gray when πcollapse was reached. 
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Figure 3.4. Brewster angle micrographs of DPPC monolayer at different surface pressures 
upon monolayer compression. 
 
For DPPC + LA monolayer spread on phosphate buffer pH 7.4, the formation of domains 
was not observed. In fact, small white aggregates can be seen as soon as monolayer 
compression started. The number and size of aggregates increased as surface pressure 
increased, as depicted in Fig. 3.5A-C. The same behavior was observed for EPC monolayer 
(Fig. 3.5D-F). 
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Figure 3.5. Brewster angle micrographs of DPPC + LA (A-C) and EPC (D-F) monolayers at 
different surface pressures upon monolayer compression. 
 
For DPPC monolayer containing AAPH in the subphase, small round gray structures 
appeared at 6.8 mN m-1 and progressed towards more complex, multilobed structures 
(Fig. 3.6A) that became less organized around 12 mN m-1 and merged at 14 mN m-1. The 
addition of Trolox to the subphase of DPPC monolayer also allowed the formation of 
multilobed domains that started to appear at similar surface pressures and remained 
organized up to higher pressure values (up to 30 mN m-1) as shown in Fig. 3.6B. This effect 
disappeared when Trolox and AAPH were both present. In fact, small round white dots 
appeared at low surface pressures (c.a. 1 mN m-1) and remained throughout the 
experiment. The formation of light gray structures was observed from 6.4 to 15.3 mN m-1, 
and their lobes were less defined (Fig. 3.6C) when compared to those of DPPC only. At 
πcollapse, the small round white dots could be still seen against a completely light gray 
background (Fig. 3.6D). 
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Figure 3.6. Brewster angle micrographs showing representative features for monolayers of 
DPPC and DPPC + LA. A, DPPC monolayer with AAPH in the subphase; B, DPPC 
monolayer with Trolox in the subphase; C, D, DPPC monolayer with AAPH and Trolox in 
the subphase; E, DPPC monolayer with α-tocopherol; F, DPPC monolayer with α-
tocopherol and AAPH in the subphase; G, DPPC + LA monolayer with AAPH in the 
subphase; H, DPPC + LA monolayer with AAPH and Trolox in the subphase. 
 
The addition of α-tocopherol to the DPPC monolayer allowed the formation of domains at 
a slightly lower surface pressure (c.a. 5.9 mN m-1). Upon compression, the small structures 
evolved to a multilobed pattern, presenting more complex features (more lobes) as shown 
in Fig. 3.6E, which collapsed into a light gray background at 14 mN m-1. When both α-
tocopherol and AAPH were present, small round white dots were also formed at low 
surface pressures. The formation of light gray domains was observed for pressures above 
7.3 mN m-1, but they presented a less smooth, slightly irregular contour as shown in Fig. 
3.6F, that merged for surface pressures above c.a. 23 mN m-1 (image not shown). 
For DPPC + LA monolayers, domain formation was again visible for all monolayers where 
antioxidants and/or AAPH were added (Fig. 3.6G and H, Fig. 3.7). Moreover, small round 
white dots were present for all experiments containing AAPH, Trolox or both compounds 
in the subphase. For experiments with α-tocopherol, branched structures could be seen 
from surface pressures above 6 mN m-1 (Fig. 3.7). These structures were white and not 
associated to the light gray domains. Furthermore, the format of the light gray domains 
was different, showing rounded borders for all experiments containing AAPH and for the 
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monolayer containing α-tocopherol. For DPPC + LA monolayer, the light gray domains 
presented irregular borders as shown in Fig. 3.6H. 
 
 
Figure 3.7. Brewster angle micrographs showing representative features for monolayers of 
DPPC + LA and α-tocopherol in phosphate buffer subphase (A-D) or with AAPH in the 
subphase (E-H). 
 
For EPC monolayers, slight changes could be observed by BAM, namely the appearance of 
small rounded light gray lipid aggregates near πcollapse. 
 
3.4 Discussion and conclusions 
 
The idea behind this work was to exploit lipid monolayers as a 2D system to provide 
insight about the effect of peroxidation, the role and interaction of antioxidants (α-
tocopherol and Trolox) with membranes, and the interaction of peroxidation products 
with lipidic domains of cell membrane. Initially, α-linolenic acid was targeted as a possible 
structure prone to peroxidation as it contains 3 double bonds (18:3;(cis)9,12,15). 
Preliminary experiments have shown that monolayer formation exclusively from this 
compound was hindered by the phosphate buffer subphase. Previous reports have 
established the feasibility of α-linolenic acid monolayer formation above a water subphase 
at 20 °C (Hac-Wydro and Wydro, 2007). However, the pKa of this fatty acid was 
determined as 8.28 in aqueous solution/dispersion, below the values of 9.24 and 9.85 
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reported for linoleic and oleic acids (Kanicky and Shah, 2002). For these two fatty acids, 
the apparent surface pKa was estimated as three units lower, namely 5.94 and 6.22, 
respectively (Tomoaiacotisel et al., 1987). This decrease on pKa value might be the result 
of the shift of pH scale in the monolayer compared to the bulk or it might also reflect an 
actual decrease of the acidity constants in monomolecular films. Hence, a similar decrease 
can be expected for linolenic acid. Therefore, for our experimental conditions, the 
apparent surface pKa of linolenic acid was probably surpassed, causing the ionization and 
dissolution of this fatty acid in the pH 7.4 subphase. 
Therefore, L-α-DPPC monolayers were chosen for further experiments. As this 
phosphatidylcholine does not possess any oxidable unsaturation on its acyl chains, mixed 
monolayers containing both DPPC and linolenic acid were evaluated as a model for 
performing the peroxidation studies. Moreover, EPC was also tested in order to evaluate if 
the DPPC + α-linolenic acid (LA) monolayer would provide a behavior similar to a more 
complex lipid mixture pertaining to biological systems. 
In fact, the addition of linolenic acid caused fluidification of DPPC monolayer, evidenced 
by the absence of any plateau in the isotherms corresponding to the LE to LC phase 
transition, by the decrease of Cs-1 and it was confirmed by BAM images, where formation 
of the typical multilobed domains from DPPC was not observed. The DPPC + LA isotherm 
was displaced towards higher areas per molecule when compared with DPPC isotherm, 
which seems opposite to the observations reported by Hac-Wydro and Wydro (Hac-Wydro 
and Wydro, 2007). Although a similar temperature was applied (20 °C), the pH of our 
experimental conditions was controlled and fostered the ionization of carboxylic group of 
linolenic acid, promoting the interaction between the negatively charged group with the 
positively charged N from the choline moiety of DPPC, with the inclusion of the linolenic 
acid hydrophobic chain among the acyl chains of DPPC (Fig. 3.8, scheme 1). 
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Figure 3.8. Schematic representations of interaction between monolayer and aqueous 
phase components. 
  
-
α
-t
o
c
ROO•
α
-t
o
c
Oxidation
productsROO
•
α
-t
o
c
Air
Aqueous
subphase
Scheme 1
Scheme 2
Scheme 3
Scheme 4
Scheme 5
Scheme 6
Air
Aqueous
subphase
Air
Aqueous
subphase
Air
Aqueous
subphase
Air
Aqueous
subphase
Air
Aqueous
subphase
α
-t
o
c
α
-t
o
c
α
-t
o
c
ROO•
PC as LE
PC as LC
peroxyl
radical
α-linolenic acid
α-tocopherol
oxidation products
from α-tocopherol
Trolox
ML compressionML compression
Chapter 3 
 
84 
 
Compared to DPPC and DPPC + LA monolayers, EPC provided an even more fluid 
monolayer, with the lowest value of Cs-1, and the highest value of Amin, existing as an 
expanded liquid. According to theoretical (Martinez-Seara et al., 2007) and experimental 
(Marsh, 1999; Murzyn et al., 2006) studies, the presence (and position) of double bonds 
affects the properties of monolayers/bilayers in the LE state, causing an increase on 
surface area per lipid. Knowing that typical lots of egg yolk phosphatidylcholine have 
esterified fatty acid contents of approximately 33% 16:0 (palmitoyl), 13% 18:0 (stearoyl), 
31% 18:1 (oleoyl) and 15% 18:2 (linoleoyl), we can consider that half of the acyl chains 
presented unsaturated bonds, justifying the features of the EPC monolayer. 
Nevertheless, DPPC, DPPC + LA and EPC monolayers presented similar Acollapse, about 47 
Å per molecule, which means that the large phosphocholine headgroup present in all 
phospholipids tested was the limiting factor of molecular area upon monolayer 
compression (Brezesinski et al., 1996; Vaknin et al., 1991). For the DPPC + LA monolayer, 
this means that the linolenic acid will be located among the acyl chains of DPPC (Hac-
Wydro and Wydro, 2007) or it may be squeezed out of the monolayer, going into the 
subphase (Fig. 3.8, scheme 2). 
Several changes were observed upon the addition of AAPH to the subphase and/or 
antioxidants to the monolayer (α-tocopherol) or to its aqueous subphase (Trolox). 
Concerning the presence of AAPH in the subphase, no significant change in the isotherm 
was observed and this was expected because DPPC acyl chains do not possess any 
unsaturated bond prone to oxidative attack. However, BAM images show a clear 
interaction between components of AAPH subphase with the monolayer through the 
change of domain shape and the appearance of white dots, located mainly at the frontier 
between LC and LE phases. In previous reports, these white structures have been 
associated to salt crystals (Benitez and Talham, 2004) or to packing defects created where 
adjacent domain edges with conflicting molecular orientations grow together during the 
LE/LC phase transition (Schief et al., 2000). In our case, these structures may derive from 
AAPH itself or from its decomposition products. The decomposition of AAPH produces 
molecular nitrogen and two carbon radicals. The carbon radicals may combine to produce 
stable products or react with molecular oxygen to give peroxyl radicals. The carbon 
radicals are formed in pairs in close proximity, some recombining to give nonreactive 
stable products (Betigeri et al., 2005). Our BAM results show that AAPH molecules and 
derivatives clearly interact with all monolayers, fostering the existence of peroxyl radicals 
in its vicinity (Fig. 3.8, scheme 3). 
One of the most important aspects was the verification that peroxyl radicals were present 
in the experimental conditions employed when the monolayer was compressed. 
Considering that the rate of free radical generation can be calculated as 1.36 × 10-6 × 
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[AAPH] × time and expressed as M s-1,(Niki, 1990) we have estimated the production of 
0.98 µmol min-1 of radical during the 10 min incubation period prior transferring 
AAPH/buffer solution to the trough. Peroxyl radicals are rather instable, starting chain 
reactions that will generate autoxidation products (peroxides and alcohols) in the absence 
of other substrates/oxidable species (Werber et al., 2011). Hence, as experiments were 
carried out at 21 °C, for which the rate of formation from AAPH is about ten times lower 
than at 37 °C, we did not expect a significant production of this radical during monolayer 
stabilization and compression. Analyzing the results shown in Fig. 3.3A, it is possible to 
ascertain that peroxyl radicals were present because a significant change in the isotherm 
of DPPC was noticed when α-tocopherol was present in the monolayer and AAPH (along 
with derived decomposition products) were in the subphase concomitantly, while no 
significant change in the isotherms was noticed when these species were added separately. 
This means that their interaction took place along the experiment in the Langmuir trough, 
in presence of peroxyl radicals that reached the monolayer. 
In fact, it has been shown that α-tocopherol intercalates into phospholipid bilayers with 
the long axis of the molecule oriented parallel to the lipid hydrocarbon chains, with the α-
tocopherol molecule able to rotate about its long axis and diffuse laterally within fluid lipid 
bilayers (Wang and Quinn, 1999). Moreover, previous studies of binary mixtures of DPPC 
(Quinn, 1995) or EPC (Naumowicz and Figaszewski, 2005) and α-tocopherol have shown 
that complexes of 10:1 stoichiometry (phospholipid:α-tocopherol) are formed. Our BAM 
results corroborate such observations as a clear change in the complexity of LC domains 
(Fig. 3.6E) was observed upon α-tocopherol incorporation into the DPPC monolayer. 
Moreover, α-tocopherol reacts with a peroxyl radical either by concerted hydrogen 
transfer or by sequential electron followed by proton transfer to form a lipid 
hydroperoxide and the tocopheroxyl radical. The stability of the tocopheroxyl radical is 
attributed to the delocalization of the unpaired electron about the fully substituted 
chromanol ring system. Reaction of the tocopheroxyl radical with a peroxyl radical yields 
two groups of products, namely 8α-substituted tocopherones and epoxy-8α-
hydroperoxytocopherones, also prone to interact with membrane bilayers (Liebler et al., 
1990; Wang and Quinn, 1999). From our results, the LC domains presented less 
organized, less defined shapes with a high number of white dots associated to the LC 
domains when both AAPH and α-tocopherol were present (Fig. 3.6F). These features 
undeniably provide further evidence of the interaction and formation of oxidation 
products that also interact with the phospholipid monolayer (Fig. 3.8, scheme 3.4). 
In Fig. 3.9 selected BAM images are presented, corresponding to the effect of α-tocopherol 
and Trolox in the DPPC monolayer at two different pressures (10 and 30 mN m-1). These 
images confirm the different interaction of each antioxidant with the monolayer, which is 
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putatively related with their location within the membrane as discussed above. In fact, for 
lower pressures (10 mN m-1), despite the maintenance of the multilobed shape of the lipid 
domains, the fluidification of the monolayer and smaller lipid domains were observed in 
the presence of Trolox. In the presence of α-tocopherol, a more complex pattern may be 
recognized, and the size of the lipid domains is similar when compared to that of DPPC 
monolayers without antioxidants. Nevertheless, for higher pressures (30 mN m-1), a more 
pronounced effect in the lipid domains was observed for α-tocopherol. Indeed, the lipid 
domains are due to the arrangement of the alkyl chains of the phospholipids, being the 
alkyl chains of the lipid in closer contact with the prenyl chains of the antioxidant. 
Contrastingly, the interaction of DPPC with Trolox is confined to the phospholipid 
headgroups, which is confirmed by the presence of a multilobed pattern even at high 
pressures. 
 
Figure 3.9. Domain patterns formed in DPPC monolayers for surface pressures of 10 and 
30 mN m-1 in absence of antioxidants and in presence of either α-tocopherol or Trolox. 
 
For DPPC + LA monolayers, the addition of any other component, AAPH or antioxidant, 
caused the reappearance of the plateau associated to the LE/LC transition of DPPC in the 
isotherms and the corresponding formation of domains observed by BAM. As all 
isotherms are similar, even in the absence of AAPH, the oxidation of LA by peroxyl 
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radicals is not the cause of LC domain formation. In fact, the absence of a plateau for 
DPPC + LA isotherm obtained for the buffer subphase indicates the miscibility between 
these two lipids, which was surpassed by the electrostatic interactions of Trolox, AAPH 
and oxidation products with the charged head groups of DPPC, causing phase segregation 
upon monolayer compression. The existence of this electrostatic interaction is further 
supported by the decrease of Acollapse observed for those experiments. The presence of LA 
(and its oxidation products) in the monolayer can be inferred by the atypical shape of 
DPPC domains (Fig. 3.6, G and H) whenever AAPH and/or Trolox were present. 
The BAM technique also allowed the observation of a white branched structure, whenever 
α-linolenic acid and α-tocopherol were present (Fig. 3.7), indicating a separation of these 
components. These branched structures are formed through van de Waals interactions, as 
described previously for a calix[8]arene derivative (Miguel et al., 2005). Association of α-
tocopherol to fatty acids have been reported before,(Kagan and Quinn, 1988; Quinn, 2012) 
bearing formation of complexes between the 3 methyl groups of the chromanol ring of α-
tocopherol and the unsaturated residues of the fatty acids (rather than the prenyl side 
chain) (Urano et al., 1993). From our BAM micrographs and known hydrophobicity of 
these compounds, the α-tocopherol-α-linolenic acid complexes seem to be located above 
or within the monolayer (Fig. 3.8, scheme 3.5), which may be considered an evidence for 
location of these complexes between the two lipidic layers that comprises the biological 
membrane or in lateral PUFA-rich segregated domains, as previously suggested by other 
authors (Atkinson et al., 2010; Quinn, 2012). 
Trolox, a soluble analogue of α-tocopherol as it possess the chroman head (including a 
hydroxyl-bearing aromatic system) and lacks the saturated hydrocarbon tail present in α-
tocopherol, has been extensively applied as standard compound in antioxidant assessment 
(Magalhães et al., 2008) and frequently in methods comprising lipidic biomimetic 
structures (Nenadis et al., 2007). Generally, Trolox is considered as an aqueous phase 
antioxidant. Our results indicate a significant interaction of Trolox with the monolayers, 
promoting the expansion of DPPC and the compression of the EPC monolayer. Moreover, 
it also promoted the stabilization of DPPC domains over a larger π range (Fig. 3.6B) 
without changing their shape, which indicates that Trolox interacts with the surface of 
DPPC monolayer (Fig. 3.8, scheme 3.6). In fact, under the experimental conditions 
applied, Trolox will present a negative charge on the carboxylic group (pKa 3.89), (Barclay 
et al., 1995) fostering its interaction with the positively charged choline group of the 
phospholipids, which justifies our observations. 
BAM images for the concomitant presence of Trolox and AAPH in the subphase of DPPC 
and DPPC + LA monolayers also showed significant differences from those taken when 
only one substance was present. Isotherms were also different for DPPC and EPC 
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monolayers. Recent work has demonstrated that Trolox reacts by adding one or two 
oxygen atoms to its phenoxyl radical, and none or little molecular rearrangement is 
undertaken. Besides, other minor by-products have been described, including those 
derived from the bond of the phenoxyl radical with the peroxyl radicals derived from 
AAPH (Bentayeb et al., 2012). These molecules can further interact with the phospholipid 
monolayer, in a way similar to Trolox because the carboxylic group is kept in the majority 
of reaction products. 
For EPC monolayers, BAM images were not useful to ascertain peroxidation/antioxidant 
protection effects. As it comprises a mixture of phosphatidylcholines that form a 
homogenous monolayer throughout the experimental conditions, domain formation was 
not observed. Nevertheless, the interaction with AAPH subphase caused a slight 
compression of the monolayer (Fig. 3.2 and 3.3, C) probably due to oxidation of the 
unsaturated acyl chains. 
The addition of either Trolox (subphase) or α-tocopherol (monolayer) promoted even 
more the monolayer compression, in this case due to the Trolox interaction with the polar 
headgroups of phosphatidylcholines (seen also here for DPPC) or due to the hydrophobic 
α-tocopherol interaction with the unsaturated acyl chains in the phospholipid through van 
der Waals forces. 
The EPC monolayer expansion observed in the presence of both AAPH and antioxidants 
may indicate a depletion of each antioxidant through competition with the EPC double 
bonds as targets of oxidation by peroxyl radicals, which can be interpreted as a protective 
effect. Nevertheless, the isotherm profile does not coincide with the initial EPC isotherm, 
surpassing it towards larger areas per EPC molecule, indicating also the interaction of 
Trolox and α-tocopherol oxidation products with the monolayer (also verified for DPPC 
monolayers). 
In conclusion, the combination of π-A isotherms and BAM imaging is a suitable 
biophysical approach to evaluate the effect of peroxidation conditions on 
phosphatidylcholine monolayers in the presence of antioxidants and oxidation targets. 
The interaction of Trolox, α-tocopherol and their peroxidation products was clearly 
ascertain, which is a relevant result when considering the current application of Trolox as 
standard in methodologies aiming the assessment of antioxidant capacity in the presence 
of lipidic structures, such as liposomes. Undeniably, it is necessary to take into 
consideration the partition between antioxidants and biomimetic lipidic structures as an 
“effective” concentration, lower than the initial aqueous concentration will be available in 
both aqueous and lipidic phases. Furthermore, the presence of peroxidation products in 
the monolayer indicates that, in methodologies where these products are measured in the 
aqueous phase, results may be biased, accounting for a lower extension of peroxidation. 
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Finally, the formation of segregated, branched shaped domains of α-tocopherol and 
linolenic acid observed for DPPC monolayers is of highly significance for biological 
systems, providing microscopic imaging evidence of the association between α-tocopherol 
and unsaturated fatty acids. 
 
 
3.5 References 
 
 
Atkinson, J.; Harroun, T.; Wassall, S. R.; Stillwell, W.; Katsaras, J. The location and 
behavior of alpha-tocopherol in membranes. Molecular Nutrition & Food Research 2010, 
54, 641-651. 
Barclay, L. R. C.; Artz, J. D.; Mowat, J. J. Partitioning and antioxidant action of the water-
soluble antioxidant, trolox, between the aqueous and lipid phases of phosphatidylcholine 
membranes: 14C tracer and product studies. Biochimica Et Biophysica Acta-
Biomembranes 1995, 1237, 77-85. 
Benitez, I. O.; Talham, D. R. Brewster angle microscopy of calcium oxalate monohydrate 
precipitation at phospholipid monolayer phase boundaries. Langmuir 2004, 20, 8287-
8293. 
Bentayeb, K.; Rubio, C.; Nerin, C. Study of the antioxidant mechanisms of Trolox and 
eugenol with 2,2 '-azobis (2-amidinepropane)dihydrochloride using ultra-high 
performance liquid chromatography coupled with tandem mass spectrometry. Analyst 
2012, 137, 459-470. 
Betigeri, S.; Thakur, A.; Raghavan, K. Use of 2,2 '-Azobis(2-amidinopropane) 
dihydrochloride as a reagent tool for evaluation of oxidative stability of drugs. 
Pharmaceutical Research 2005, 22, 310-317. 
Brezesinski, G.; Thoma, M.; Struth, B.; Mohwald, H. Structural changes of monolayers at 
the air/water interface contacted with n-alkanes. Journal of Physical Chemistry 1996, 
100, 3126-3130. 
Cubillos, M.; Lissi, E.; Abuin, E. Lipid peroxidation rates of DPPC liposomes containing 
different amounts of oxidable lipids show opposite dependence with the temperature. 
Journal of the Chilean Chemical Society 2006, 51, 825-828. 
Cuzzocrea, S.; Riley, D. P.; Caputi, A. P.; Salvemini, D. Antioxidant therapy: A new 
pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. 
Pharmacological Reviews 2001, 53, 135-159. 
Chapter 3 
 
90 
 
Cwiklik, L.; Jungwirth, P. Massive oxidation of phospholipid membranes leads to pore 
creation and bilayer disintegration. Chemical Physics Letters 2010, 486, 99-103. 
Duncan, S. L.; Larson, R. G. Comparing experimental and simulated pressure-area 
isotherms for DPPC. Biophysical Journal 2008, 94, 2965-2986. 
Edidin, M. Timeline - Lipids on the frontier: a century of cell-membrane bilayers. Nature 
Reviews Molecular Cell Biology 2003, 4, 414-418. 
Fadel, O.; El Kirat, K.; Morandat, S. The natural antioxidant rosmarinic acid 
spontaneously penetrates membranes to inhibit lipid peroxidation in situ. Biochimica Et 
Biophysica Acta-Biomembranes 2011, 1808, 2973-2980. 
Hac-Wydro, K.; Wydro, P. The influence of fatty acids on model cholesterol/phospholipid 
membranes. Chemistry and Physics of lipids 2007, 150, 66-81. 
Halliwell, B.; Gutteridge, J. M. C., Free radicals in biology and medicine. 4th ed.; Oxford 
University Press: Oxford, 2007. 
Jacob, R. F.; Mason, R. P. Lipid peroxidation induces cholesterol domain formation in 
model membranes. Journal of Biological Chemistry 2005, 280, 39380-39387. 
Kagan, V. E.; Quinn, P. J. The interaction of alpha-tocopherol and homologs with shorter 
hydrocarbon chains with phospholipid-bilayer dispersions - a fluorescence probe study. 
European Journal of Biochemistry 1988, 171, 661-667. 
KamalEldin, A.; Appelqvist, L. A. The chemistry and antioxidant properties of tocopherols 
and tocotrienols. Lipids 1996, 31, 671-701. 
Kanicky, J. R.; Shah, D. O. Effect of degree, type, and position of unsaturation on the 
pK(a) of long-chain fatty acids. Journal of Colloid and Interface Science 2002, 256, 201-
207. 
Khabiri, M.; Roeselova, M.; Cwiklik, L. Properties of oxidized phospholipid monolayers: 
An atomistic molecular dynamics study. Chemical Physics Letters 2012, 519-20, 93-99. 
Klopfer, K. J.; Vanderlick, T. K. Isotherms of dipalmitoylphosphatidylcholine (DPPC) 
monolayers: Features revealed and features obscured. Journal of Colloid and Interface 
Science 1996, 182, 220-229. 
Leekumjorn, S.; Cho, H. J.; Wu, Y. F.; Wright, N. T.; Sum, A. K.; Chan, C. The role of fatty 
acid unsaturation in minimizing biophysical changes on the structure and local effects of 
bilayer membranes. Biochimica Et Biophysica Acta-Biomembranes 2009, 1788, 1508-
1516. 
Chapter 3 
 
91 
 
Liebler, D. C.; Baker, P. F.; Kaysen, K. L. Oxidation of vitamin-e - evidence for competing 
autoxidation and peroxyl radical trapping reactions of the tocopheroxyl radical. Journal of 
the American Chemical Society 1990, 112, 6995-7000. 
Lúcio, M.; Nunes, C.; Gaspar, D.; Ferreira, H.; Lima, J. L. F. C.; Reis, S. Antioxidant 
Activity of Vitamin E and Trolox: Understanding of the Factors that Govern Lipid 
Peroxidation Studies In Vitro. Food Biophysics 2009, 4, 312-320. 
Magalhães, L. M.; Segundo, M. A.; Reis, S.; Lima, J. L. F. C. Methodological aspects about 
in vitro evaluation of antioxidant properties. Analytica Chimica Acta 2008, 613, 1-19. 
Marsh, D. Thermodynamic analysis of chain-melting transition temperatures for 
monounsaturated phospholipid membranes: Dependence on cis-monoenoic double bond 
position. Biophysical Journal 1999, 77, 953-963. 
Martinez-Seara, H.; Rog, T.; Pasenkiewicz-Gierula, M.; Vattulainen, I.; Karttunen, M.; 
Reigada, R. Effect of double bond position on lipid bilayer properties: Insight through 
atomistic simulations. Journal of Physical Chemistry B 2007, 111, 11162-11168. 
Mason, R. P.; Walter, M. F.; Mason, P. E. Effect of oxidative stress on membrane 
structure: Small-angle x-ray diffraction analysis. Free Radical Biology and Medicine 
1997, 23, 419-425. 
McLean, L. R.; Hagaman, K. A. Effect of lipid physical state on the rate of peroxidation of 
liposomes. Free Radical Biology and Medicine 1992, 12, 113-119. 
Miguel, G.; Pedrosa, J. M.; Martin-Romero, M. T.; Munoz, E.; Richardson, T. H.; 
Camacho, L. Conformational changes of a calix[8]arene derivative at the air-water 
interface. Journal of Physical Chemistry B 2005, 109, 3998-4006. 
Mitsche, M. A.; Wang, L. B.; Small, D. M. Adsorption of egg phosphatidylcholine to an 
air/water and triolein/water bubble interface: use of the 2-dimensional phase rule to 
estimate the surface composition of a phospholipid/triolein/water surface as a function of 
surface pressure. Journal of Physical Chemistry B 2010, 114, 3276-3284. 
Mowri, H.; Nojima, S.; Inoue, K. Effect of lipid-composition of liposomes on their 
sensitivity to peroxidation. Journal of Biochemistry 1984, 95, 551-558. 
Mueller, N. S.; Wedlich-Soeldner, R.; Spira, F. From mosaic to patchwork: Matching lipids 
and proteins in membrane organization. Molecular Membrane Biology 2012, 29, 186-
196. 
Murzyn, K.; Zhao, W.; Karttunen, M.; Kurdziel, M.; Rog, T. Dynamics of water at 
membrane surfaces: Effect of headgroup structure. Biointerphases 2006, 1, 98-105. 
Chapter 3 
 
92 
 
Naumowicz, M.; Figaszewski, Z. A. Impedance analysis of phosphatidylcholine/alpha-
tocopherol system in bilayer lipid membranes. Journal of Membrane Biology 2005, 205, 
29-36. 
Nenadis, N.; Lazaridou, O.; Tsimidou, M. Z. Use of reference compounds in antioxidant 
activity assessment. Journal of Agricultural and Food Chemistry 2007, 55, 5452-5460. 
Niki, E. Antioxidants in relation to lipid-peroxidation. Chemistry and Physics of lipids 
1987, 44, 227-253. 
Niki, E. Free-radical initiators as source of water-soluble or lipid-soluble peroxyl radicals. 
Methods in Enzymology 1990, 186, 100-108. 
Nugent, T.; Jones, D. T. Membrane protein structural bioinformatics. Journal of 
Structural Biology 2012, 179, 327-337. 
Nunes, C.; Brezesinski, G.; Pereira-Leite, C.; Lima, J. L. F. C.; Reis, S.; Lúcio, M. NSAIDs 
interactions with membranes: a biophysical approach. Langmuir 2011, 27, 10847-58. 
Quinn, P. J. Characterization of clusters of alpha-tocopherol in gel and fluid phases of 
dipalmitoylglycerophosphocholine. European Journal of Biochemistry 1995, 233, 916-
925. 
Quinn, P. J. Lipid-lipid interactions in bilayer membranes: Married couples and casual 
liaisons. Progress in Lipid Research 2012, 51, 179-198. 
Reis, S.; Lúcio, M.; Segundo, M.; Lima, J. L. F. C., Use of Liposomes to Evaluate the Role 
of Membrane Interactions on Antioxidant Activity. In Liposomes: Methods and Protocols, 
Vol 2: Biological Membrane Models, Weissig, V., Ed. Humana Press Inc: Totowa, 2010; 
Vol. 606, pp 167-188. 
Rigoletto, T. d. P.; Zaniquelli, M. E. D.; Santana, M. H. A.; de la Torre, L. G. Surface 
miscibility of EPC/DOTAP/DOPE in binary and ternary mixed monolayers. Colloids and 
surfaces. B, Biointerfaces 2011, 83, 260-9. 
Schief, W. R.; Touryan, L.; Hall, S. B.; Vogel, V. Nanoscale topographic instabilities of a 
phospholipid monolayer. Journal of Physical Chemistry B 2000, 104, 7388-7393. 
Schnitzer, E.; Pinchuk, I.; Lichtenberg, D. Peroxidation of liposomal lipids. European 
Biophysics Journal with Biophysics Letters 2007, 36, 499-515. 
Tomoaiacotisel, M.; Zsako, J.; Mocanu, A.; Lupea, M.; Chifu, E. Insoluble mixed 
monolayers .3. The ionization characteristics of some fatty-acids at the air-water-interface. 
Journal of Colloid and Interface Science 1987, 117, 464-476. 
Chapter 3 
 
93 
 
Tsuchiya, H.; Ueno, T.; Tanaka, T.; Matsuura, N.; Mizogami, M. Comparative study on 
determination of antioxidant and membrane activities of propofol and its related 
compounds. European Journal of Pharmaceutical Sciences 2010, 39, 97-102. 
Urano, S.; Matsuo, M.; Sakanaka, T.; Uemura, I.; Koyama, M.; Kumadaki, I.; Fukuzawa, K. 
Mobility and molecular-orientation of vitamin E in liposomal membranes as determined 
by 19F NMR and fluorescence polarization techniques. Archives of Biochemistry and 
Biophysics 1993, 303, 10-14. 
Vaknin, D.; Kjaer, K.; Alsnielsen, J.; Losche, M. Structural-properties of 
phosphatidylcholine in a monolayer at the air-water-interface - neutron reflection study 
and reexamination of X-ray reflection measurements. Biophysical Journal 1991, 59, 
1325-1332. 
Valko, M.; Rhodes, C. J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and 
antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006, 
160, 1-40. 
Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M. T. D.; Mazur, M.; Telser, J. Free radicals 
and antioxidants in normal physiological functions and human disease. International 
Journal of Biochemistry & Cell Biology 2007, 39, 44-84. 
Volinsky, R.; Paananen, R.; Kinnunen, P. K. J. Oxidized Phosphatidylcholines Promote 
Phase Separation of Cholesterol-Sphingomyelin Domains. Biophysical Journal 2012, 
103, 247-254. 
Wang, X. Y.; Quinn, P. J. Vitamin E and its function in membranes. Progress in Lipid 
Research 1999, 38, 309-336. 
Werber, J.; Wang, Y. J.; Milligan, M.; Li, X. H.; Ji, J. A. Analysis of 2,2 '-Azobis (2-
Amidinopropane) Dihydrochloride Degradation and Hydrolysis in Aqueous Solutions. 
Journal of Pharmaceutical Sciences 2011, 100, 3307-3315. 
Wong-Ekkabut, J.; Xu, Z. T.; Triampo, W.; Tang, I. M.; Tieleman, D. P.; Monticelli, L. 
Effect of lipid peroxidation on the properties of lipid bilayers: A molecular dynamics 
study. Biophysical Journal 2007, 93, 4225-4236. 
 
 
  
 
 
 
 
 
 
  
CHAPTER 4 
Interaction of soluble biological 
antioxidants with phosphatidylcholine 
monolayers 
 
 
Chapter 4 
 
95 
 
4. Interaction of soluble biological antioxidants with 
phosphatidylcholine monolayers 
 
 
4.1 Introduction 
 
 
Membranes of eukaryotic cells act as barriers between separate functional compartments 
and, at the same time, the cell-surface membrane is the frontier between the cell and its 
environment. Exploration of this frontier has revealed its physical and functional 
properties. The plasma membrane is a lipid bilayer, the composition of which regulates 
frontier crossing by molecules between the cell surroundings and its interior, and the 
properties of the bilayer are different from those of any of its components alone (Edidin, 
2003). Over the years the study of the bilayer has aroused much interest in order to better 
understand the possible structural, physical and chemical changes due to interactions 
between the bilayer components and other compounds. 
Biological membranes generally contain mixtures of lipids that vary with respect to both 
their polar headgroups and their acyl chains. It has been admitted that the primary 
organizing force in the formation of these systems is dominated by the contribution of 
hydrophobic and hydrophilic effects (Gzyl-Malcher et al., 2009). 
Lipid peroxidation has been a central aspect of studies about the nature of free radical 
species and their origin in biological systems (Sevanian and Ursini, 2000), once the free 
radicals and other so-called “reactive species” are constantly produced in vivo by all body 
tissues (Halliwell, 2001). Moreover, there has been a growing interest in lipid peroxidation 
based on evidence that biologically active products are formed that influence cell function 
and the course of major human diseases (Sevanian and Ursini, 2000). This uncontrolled 
reaction generates cytotoxic compounds and disrupts the various important structural and 
protective function associated with biomembranes, being implicated in the etiology of 
many diseases, including cancer, cardiovascular and neurological diseases, and other 
oxidative stress mediated dysfunctions. 
Free radicals and reactive nonradical species derived from radicals exist in biological cells 
and tissues at low but measurable concentrations. Their concentrations are determined by 
the balance between their rates of production and their rates of clearance by various 
antioxidant compounds and enzymes (Droge, 2002). 
Over the years biomimetic models and new techniques were used to understand the 
biological membranes and the role of the antioxidants (defined as an inhibitor of lipid 
peroxidation, namely biological antioxidants including glutathione, ascorbic acid and uric 
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acid). These molecules have a relevant role on protecting membranes from peroxidation 
and lipid peroxidation propagation (promoted by attack of lipid molecules), either by the 
capability to scavenge free radicals, or by interacting with membranes and changing their 
biophysical properties in a way that favors their interaction with lipid radicals (Reis et al., 
2010). The relatively high intracellular concentrations of glutathione and other 
antioxidative compounds provide a strong basal scavenging capacity (Droge, 2002). 
Glutathione is currently one of the most studied antioxidant because it is endogenously 
synthesized all throughout the body and found in all cells, sometimes in rather high 
concentrations. For example, the response of glutathione has been frequently studied 
during intense exercise, because the oxidized glutathione levels increased in the blood 
after exercise, suggesting an increase in oxidative stress. A decreased level of glutathione 
in the plasma is the result of an increased utilization of it inside the muscle, presumably to 
fight or “quench” any circulating free radicals (Kerksick and Willoughby, 2005). 
The ascorbic acid is a key water-soluble antioxidant due to its ability to interact with ROS 
and to reduce the radicals formed from α-tocopherol and β-carotene (Sharma and 
Buettner, 1993). The participation in various free-radical processes is a likely cause of the 
known immunomodulating and antiviral properties of ascorbic acid (Furuya et al., 2008; 
Jariwalla et al., 2007; Uchide and Toyoda, 2011). Its aqueous solutions are easily oxidized 
(Capuzzi et al., 1996) but it is widely used as vitaminous, regenerative and antiviral 
medication in the treatment of various respiratory viral infections including influenza, 
herpetic infections, viral hepatitis and other infectious diseases (Brinkevich et al., 2012). 
At physiological pH almost all uric acid is ionized to urate (Halliwell and Gutteridge, 
2007). Urate is a powerful scavenger of ROS in vitro. Indeed, it was proposed that it works 
as a biological antioxidant and it was also further suggested that loss of urate oxidase was 
advantageous to primates since it simultaneously removed a source of H2O2 (from urate 
oxidase) and allowed a powerful antioxidant to accumulate (Ames et al., 1981). 
In this context, the present work aims to provide a biophysical approach to assess the 
effect of peroxyl radicals resulting from a hydrophilic generator, 2,2′-azobis (2-
amidinopropane) dihydrochloride (AAPH), and natural antioxidants with relevant role in 
biological systems: glutathione, ascorbic acid and uric acid. Biomembranes were 
mimicked using lipid monolayers as membrane model systems, since this provides a 
convenient model for understanding bilayer structures. Furthermore, since monolayers 
can be studied in a Langmuir trough, where both the temperature and the mean molecular 
area can be controlled, we were able to probe some aspects of the liquid expanded to liquid 
condensed phase transition. Different lipid compositions characteristic of the 
biomembranes were used: DPPC (L-α-dipalmitoylphosphatidylcholine), DPPC:linolenic 
acid (9:1), and EPC (L-α-phosphatidylcholine). The extensive range of peroxidation related 
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phenomena and monolayer structural changes were analyzed both by π/A isotherms and 
Brewster Angle Microscopy (BAM). 
 
 
4.2 Reagents and solutions 
 
 
Egg yolk phosphatidylcholine (EPC), potassium phosphate monobasic, 2,2'-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), uric acid, glutathione, ascorbic acid and 
α-linolenic acid (LA)  were purchased from Sigma-Aldrich (St. Louis, MO). L-α-
dipalmitoylphosphatidylcholine (DPPC) was purchased from Avanti Polar Lipids Inc. 
Chloroform from Landilab (Porto, Portugal) was used as co-spreading solvent. The 
subphase used, 75 mM hydrogen phosphate/phosphate buffer (pH 7.4), was prepared 
using Milli-Q water (resistivity > 18.2 MΩ cm, Millipore, Billerica, MA). 
Lipid solutions were prepared in chloroform and they contained DPPC (0.734 mg mL-1), 
DPPC + LA (9:1, w/w; 0.642 mg mL-1 of DPPC) or EPC (0.751 mg mL-1). Uric acid, 
glutathione, ascorbic acid were added to the subphase buffer at 20 µM. For generation of 
peroxyl radicals, AAPH (12 mM) was dissolved in hydrogen phosphate buffer at 37 °C and 
kept at this temperature during 10 minutes. Whenever necessary, uric acid, glutathione, 
and ascorbic acid were dissolved in this solution immediately before its transfer into the 
trough.  
 
4.3 Results 
 
 
4.3.1 π-A measurements 
 
 
The isotherms of DPPC, DPPC + LA and EPC spread above subphases containing AAPH, 
antioxidant (glutathione, ascorbic acid or uric acid) or these two compounds 
concomitantly are given in Fig. 4.1-4.3. DPPC isotherms present the typical plateau at 5 – 
8 mN m-1, corresponding to the first order phase transition from LE to LC. This plateau 
was displaced towards higher areas per molecule for subphases containing the antioxidant 
and AAPH. This effect was further enhanced for glutathione, where the transition pressure 
was also higher (9.4 mN m-1 compared to 6.2 mN m-1 observed for phosphate buffer 
subphase). 
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Figure 4.1. Surface pressure-area isotherms for different lipid systems, with monolayers 
formed and compressed above subphases containing phosphate buffer pH 7.4 (▬), AAPH 
solution (▬), glutathione solution (▬), and AAPH + glutathione solution (▬). The solid 
bars represent the area per DPPC molecule where LC domains can be visualized by BAM. 
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Figure 4.2. Surface pressure-area isotherms for different lipid systems, with monolayers 
formed and compressed above subphases containing phosphate buffer pH 7.4 (▬), AAPH 
solution (▬), ascorbic acid solution (▬), and AAPH + ascorbic acid solution (▬). The 
solid bars represent the area per DPPC molecule where LC domains can be visualized by 
BAM. 
0 20 40 60 80 100 120 140 160
0
10
20
30
40
50
60
70
Su
rfa
c
e 
pr
es
su
re
-
pipi pipi
, 
(m
N
m
-
1 )
Area per EPC molecule ( Å2/molecule)
0 20 40 60 80 100 120 140 160
0
10
20
30
40
50
60
70
Su
rfa
ce
 
pr
es
su
re
-
pipi pipi
, 
m
N
m
-
1
Area per DPPC molecule ( Å2/molecule)
0 20 40 60 80 100 120 140 160
0
10
20
30
40
50
60
70
Su
rfa
ce
 
pr
es
su
re
-
pipi pipi
, 
m
N
m
-
1
Area per DPPC molecule ( Å2/molecule)
DPPC + LA
DPPC
EPC
Chapter 4 
 
100 
 
 
Figure 4.3. Surface pressure-area isotherms for different lipid systems, with monolayers 
formed and compressed above subphases containing phosphate buffer pH 7.4 (▬), AAPH 
solution (▬), uric acid solution (▬), and AAPH + uric acid solution (▬). The solid bars 
represent the area per DPPC molecule where LC domains can be visualized by BAM. 
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The DPPC + LA isotherm for the phosphate buffer subphase does not show any plateau 
corresponding to phase transition. However, when any of the tested compounds is added 
to the subphase, a plateau similar to that observed for monolayers containing DPPC only 
is achieved. For subphases containing each of the antioxidants tested, the isotherm for low 
π values (up to 95 Å2 per molecule) is similar to that obtained for the phosphate buffer 
subphase. For lower areas per molecule, a plateau is observed up to 68 Å2 per molecule, 
from which the area per molecule changes much less upon monolayer compression. 
Whenever AAPH was present in the subphase of DPPC + LA monolayer, the surface 
pressure starts to rise from larger areas per molecule (140 Å2 per molecule) when 
compared to other subphases without this component (110 – 120 Å2 per molecule). 
Moreover, the whole isotherm profile is shifted towards large areas per molecule, while 
the plateau zone is less evident when only AAPH is present. The concomitant addition of 
AAPH and any antioxidant to the subphase makes the isotherm shift slightly towards 
larger areas per molecule before the LE/LC transition and towards lower areas per 
molecule when the phosphatidylcholine exists as LC, compared to the DPPC + LA 
isotherm. In fact, isotherms from subphases containing AAPH and antioxidant are placed 
between the isotherms from subphases containing only one of these components. 
πcollapse and Acollapse are similar for DPPC and DPPC + LA systems for all experiments when 
any of the compounds tested were added to the monolayer subphase, with values of c.a. 60 
mN m-1 and 30 Å2 per molecule, respectively (Table 4.1). These values are different from 
those attained for the monolayers spread above phosphate buffer, for which πcollapse and 
Acollapse were c.a. 51 mN m-1 and 47 Å2 per molecule, respectively. Addition of AAPH in 
particular caused Cs-1 to converge to a similar value in both systems (142 and 160 mN m-1), 
resulting in a more compressible monolayer for DPPC + LA and less compressible for 
DPPC. 
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Table 4.1. Characteristic parameters (elastic modulus, collapse pressure and collapse 
area) of the Langmuir monolayers tested on aqueous subphases containing the 
peroxidation inducer (AAPH) and antioxidants (glutathione, ascorbic acid, uric acid) 
 
 
Lipid system Subphase Cs-1 
(mN m-1) 
πcollapse 
(mN m-1) 
Acollapse 
(Å per molecule) 
DPPC Phosphate buffer pH 7.4 
a 
248 53 ± 1 47.1 ± 1.0 
 AAPH a 142 62 ± 1 33.6 ± 0.3 
 Glutathione 240 60 ± 6 33.0 ± 5.2 
 Glutathione + AAPH 285 61 ± 1 34.6 ± 0.0 
 Ascorbic acid 219 62 ± 6 31.3 ± 5.7 
 Ascorbic acid + AAPH 179 62 ± 3 29.5 ± 2.4 
 Uric acid 242 59 ± 2 29.3 ± 1.8 
 Uric acid + AAPH 211 62 ± 3 29.5 ± 2.7 
DPPC + LA Phosphate buffer pH 7.4 
a 
117 49 ± 1 47.8 ± 1.1 
 AAPH a 160 63 ± 1 34.7 ± 1.3 
 Glutathione 223 61 ± 1 34.7 ± 0.7 
 Glutathione + AAPH 213 60 ± 1 35.2 ± 2.6 
 Ascorbic acid 203 61 ± 5 33.4 ± 0.4 
 Ascorbic acid + AAPH 176 63 ± 1 31.3 ± 0.1 
 Uric acid 185 59 ± 2 29.3 ± 1.8 
 Uric acid + AAPH 218 62 ± 3 29.5 ± 2.7 
EPC Phosphate buffer pH 7.4 
a 
93 42 ± 1 46.1 ± 2.8 
 AAPH a 96 45 ± 1 46.1 ± 1.1 
 Glutathione 91 45 ± 1 55.7 ± 8.5 
 Glutathione + AAPH 95 46 ± 1 59.2 ± 1.8 
 Ascorbic acid 80 45 ± 1 46.2 ± 1.0 
 Ascorbic acid + AAPH 129 46 ± 1 57.5 ± 2.7 
 Uric acid 146 45 ± 1 66.4 ± 5.4 
 Uric acid + AAPH 138 45 ± 1 56.4 ± 2.3 
 
For EPC monolayers, no plateau corresponding to phase transitions is observed in the 
isotherms. Acollapse values are increased for all subphases (56 – 66 Å2 per molecule), except 
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for that containing ascorbic acid, where Acollapse was similar to that observed for EPC 
placed above phosphate buffer (46 Å2 per molecule). 
Addition of AAPH causes the isotherm to shift towards lower area per molecule, they have 
similar shape to EPC isotherm for phosphate buffer. 
Whenever AO was present, the shape of isotherm changed slightly with apparently higher 
slopes at higher π. The behavior for each AO was different. For glutathione subphase, the 
initial area per molecule is slightly lower (115 Å2 vs 140 Å2 for phosphate buffer), but from 
π = 15 mN m-1 the two isotherms coincided. When AAPH was added with glutathione, the 
initial area per molecule was increased to 160 Å2 per molecule and the whole isotherm was 
shifted towards higher areas. 
For ascorbic acid subphase, the initial area per molecule is even lower (95 Å2) and the 
isotherm is completely shifted towards lower areas per molecule. Addition of AAPH to 
ascorbic acid subphase originated an isotherm with a similar shape of that with ascorbic 
acid subphase, starting at an area per molecule similar to that of phosphate buffer 
isotherm and ending at a higher Acollapse (57 Å2 per molecule). 
For uric acid subphase, an opposite behavior was observed because all isotherms started 
at similar area per molecule values and the isotherm from the subphase containing uric 
acid is more displaced towards larger areas per molecule than that containing both uric 
acid and AAPH. 
 
 
4.3.2 BAM observation 
 
 
For DPPC monolayers, domain formation during the phase transition between LE and LC 
was observed for all subphases. Nevertheless, their formation began at larger areas per 
molecule for subphases containing both antioxidant and AAPH (c.a. 95 Å2 per molecule 
compared to 78 to 86 Å2 per molecule for other subphases). Moreover, the shape and 
surface pressure interval where they exist changed for different subphases. In Fig. 4.4 
BAM images showing typical domain features are given for all subphases and monolayers 
tested. For DPPC monolayer spread on phosphate buffer subphase, typical multilobed 
domains, with four lobes, were seen for areas per molecule between 57 and 65 Å2 (π 
between 7 and 14 mN m-1) and they merged in a light gray background for π over 33 mN 
m-1. When AAPH was added to the subphase, similar domains were observed at larger π 
values (12 – 16 mN m-1), which formed a complete light gray background for π over 27 mN 
m-1. When glutathione was added to DPPC monolayer subphase, multilobed domains were 
also formed, along with simpler two lobed structures. They also incorporate small white 
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dots associated to the contour of the domains, corresponding to the interface between LE 
and LC phases. They became less organized at lower π values (10 mN m-1), forming a 
homogeneous background from 15 mN m-1. When both glutathione and AAPH were 
present in the subphase, the white dots became larger and the domain contours became 
less defined. 
For the subphase containing ascorbic acid, multilobed domains bearing 3 lobes can be 
seen among branched white structures. In opposition to the white dots observed for 
glutathione subphase, these branched structures are not clearly associated to the DPPC 
domains, but they existed in π and area per molecule intervals similar to that observed for 
the glutathione subphase. The concomitant presence of AAPH and ascorbic acid provided 
domains with less defined contour and the branched structures were still observed. 
Similar results were obtained for the uric acid subphase, with longer white branched 
structures that appeared as long as π became larger than zero. 
For DDPC + LA monolayers, typical domain formation from DPPC is not observed. In fact, 
some round white lipid aggregates could be seen at high π (c.a. 40 mN m-1, Fig. 4.4). As 
observed for the isotherms, the addition of any component (AAPH or antioxidants or 
both) to the subphase allowed the appearance of domain structures from DPPC. These 
structures were quite similar to those observed for DPPC monolayers when glutathione or 
glutathione and AAPH were present in the subphase. For ascorbic acid, the white 
branched forms disappeared and the domain shape had sharp edges, with lower size and 
multiple configurations (Fig. 4.4). When both ascorbic acid and AAPH were present, the 
domain shape looks more similar to that of DPPC concerning the existence of a round 
contour, but without the multilobed shape. 
The opposite behavior was presented when uric acid was present in the subphase because 
round, multilobed domains were observed for DDPC + LA monolayers. When uric acid 
and AAPH were both present in the subphase, the domain shape changed, showing sharp 
edges, as observed for ascorbic acid subphase. 
For EPC, domain formation was not observed. Small white aggregates could also be seen 
at large π (c.a. 30 mN m-1), for all subphases. When AAPH was added to subphases 
containing either ascorbic or uric acid, the small white branched structures disappeared. 
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4.4 Discussion 
 
 
The addition of glutathione, ascorbic acid or uric acid to the subphase of DPPC 
monolayers did not cause any changes in the shape of π-A isotherms but a clear 
interaction with the monolayer can be seen in the BAM micrographs (Fig. 4.4). 
Glutathione presented the formation of white dots, corresponding to centers where 
formation of DPPC at condensed liquid state took place (Benitez and Talham, 2004; Schief 
et al., 2000). For ascorbic and uric acid, the brightest structures are more complex and do 
not seem to be particularly associated to any specific place of the condensed DPPC 
domains. These results may be justified by the different charges presented by these 
molecules. DPPC, bearing the phosphatidylcholine head in contact with the aqueous 
subphase, presents a positive charge in the choline group and a negative charge in the 
phosphatidyl moiety. Glutathione at pH 7.4 present a neutral net charge, with a positive 
charge on its glutamic acid residue and a negative charge on its carboxylic group from the 
glycine residue (Bieri and Burgi, 2005). This aspect can foster strong association between 
this molecule and the polar heads of DPPC. Concerning ascorbic and uric acids, both 
molecules present a negative net charge at our experimental pH. Ascorbic acid has two 
ionizable hydroxyl groups, with pKa of 4.25 and 11.5, respectively, resulting in the 
predominance of its monoanion form at physiological pH. In the case or uric acid, it 
presents a single negative charge at physiological pH as its pKa is 5.4 (Bieri and Burgi, 
2005; Halliwell and Gutteridge, 2007). Hence, these molecules can only interact with the 
choline moiety of the PC, originating similar BAM micrographs. 
When linolenic acid was added to the DPPC monolayer, the two components were 
miscible during monolayer compression with formation of brighter round aggregates, 
corresponding to linolenic acid segregation, only at high surface pressures. In fact, the 
collapse pressure was lower, with a value probably corresponding to the weighted average 
of values for monolayers with DPPC or LA only. 
The addition of antioxidants changed the miscibility between the two lipids because the 
plateau corresponding to the LE/LC phase transition of DPPC reappeared and the 
formation of DPPC domains was again visible by BAM. Furthermore, their interaction 
with the monolayer seems to be more consolidated as the white bright structure appeared 
less frequently when compared to BAM micrographs taken in the absence of linolenic acid. 
The shape of domains was similar for glutathione and uric acid, with the multilobed 
pattern observed for DPPC monolayers. For ascorbic acid, the shape was different, with 
elongated borders, and larger, empty spaces near the center of the domain. These can be 
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caused due to electrostatic interaction between ascorbate and the positively charged 
choline moiety present on the polar head of DPPC. 
The addition of AAPH to subphases containing the antioxidant compounds generated 
oxidation products from the antioxidants that also interacted with the DPPC monolayer. 
This observation is supported by the shift of isotherms towards higher areas per DPPC 
molecule, indicating a stronger interaction, even an intercalation in the monolayer as the 
change towards higher areas occur also for the highest surface pressures attained. For 
glutathione this interaction is even stronger, probably caused by the formation of larger 
dimer molecules (oxidized glutathione) formed when two glutathione molecules join 
together as the thiol groups of cysteine oxidize to form a disulfide bridge. These aspects 
are also supported by the BAM micrographs, as white structures are also visible, along 
with DPPC domains (light gray structures). 
For ascorbic acid, oxidation products are mainly a dehydroascorbic derivative, whose ring 
is opened in aqueous solution and further oxidized to form a dicarboxylic compound. Uric 
acid is oxidized by peroxyl radicals, forming the urate radical, which is considerably more 
stable than peroxyl radicals (Domazou et al., 2012). All these oxidation products are 
known to interact with lipidic or hydrophobic structures and here we have biophysical 
evidence of these interactions. 
For EPC monolayers, which bear a more close resemblance to biological membranes, 
peroxyl radicals formed from AAPH induced oxidation of the unsaturated bonds as shown 
by the displacement of isotherm towards lower molecular areas, caused by formation of 
shorter chains and the elimination of unsaturated acyl chains bearing kinks. These two 
features make phospholipid molecules to be placed close to each other. 
When glutathione was added to the subphase of EPC, changes in the isotherm indicate a 
superficial interaction of this molecule with the polar heads of phospholipids because of 
monolayer expansion only for lower superficial pressures. Upon peroxidation, this 
interaction was changed because the whole isotherm was displaced, indicating the 
intercalation of glutathione oxidation products (dimeric molecules, as mentioned before) 
in the EPC monolayer. 
Ascorbic acid also showed interaction with the polar head groups of EPC, with a stronger 
character than that shown by glutathione because the interaction was maintained for 
higher surface pressures and originated a more compact monolayer (lower area per 
molecule). 
The interaction of uric acid, that exists predominantly as urate under our experimental 
conditions, and EPC monolayer is different considering the isotherm displacement. This is 
probably caused by the intercalation of urate molecules deeper into the monolayer, 
through interaction of its negative charge with the choline group of the PCs heads and also 
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through van der Waals interaction between the purine moiety and the double bonds 
present in EPC acyl chains. When AAPH is added to this subphase, the isotherm has a 
similar shape but shifts towards lower areas per molecule. This may occur for two reasons. 
Firstly, there is a depletion of the urate pool, oxidized by peroxyl radicals, reducing the 
presence of urate in the monolayer and originating a lower expansion. Secondly, urate 
radicals formed from the reaction between urate and peroxyl radicals can also attack the 
double bonds of EPC, causing monolayer compression as explained above. 
In conclusion, the biological significance of our observations resides on the fact that 
typically aqueous antioxidants also interact with the 2D lipidic model studied here. Hence, 
this interaction should always be regarded when evaluating antioxidant capacity using 
biomimetic models of the membrane. Furthermore, different types of interaction were 
observed, comprising intercalation into the monolayer or adsorption into its surface. For 
all antioxidants, interactions with the monolayer surface were typically seen for pure 
compounds, while evidence for a higher degree of monolayer penetration was gathered for 
oxidation products. This aspect deserves further study as it hints to a possible 
accumulation of oxidation/peroxidation products in cell membranes. 
 
4.5 References 
 
 
Ames, B. N.; Cathcart, R.; Schwiers, E.; Hochstein, P. Uric-acid provides an antioxidant 
defense in humans against oxidant-caused and radical-caused aging and cancer - a 
hypothesis. Proceedings of the National Academy of Sciences of the United States of 
America-Biological Sciences 1981, 78, 6858-6862. 
Benitez, I. O.; Talham, D. R. Brewster angle microscopy of calcium oxalate monohydrate 
precipitation at phospholipid monolayer phase boundaries. Langmuir 2004, 20, 8287-
8293. 
Bieri, M.; Burgi, T. L-Glutathione chemisorption on gold and acid/base induced structural 
changes: A PM-IRRAS and time-resolved in situ ATR-IR spectroscopic study. Langmuir 
2005, 21, 1354-1363. 
Brinkevich, S. D.; Boreko, E. I.; Savinova, O. V.; Pavlova, N. I.; Shadyro, O. I. Radical-
regulating and antiviral properties of ascorbic acid and its derivatives. Bioorganic & 
Medicinal Chemistry Letters 2012, 22, 2424-2427. 
Chapter 4 
 
109 
 
Capuzzi, G.; LoNostro, P.; Kulkarni, K.; Fernandez, J. E. Mixtures of stearoyl-6-O-ascorbic 
acid and alpha-tocopherol: A monolayer study at the gas/water interface. Langmuir 
1996, 12, 3957-3963. 
Domazou, A. S.; Zhu, H.; Koppenol, W. H. Fast repair of protein radicals by urate. Free 
Radical Biology and Medicine 2012, 52, 1929-1936. 
Droge, W. Free radicals in the physiological control of cell function. Physiological Reviews 
2002, 82, 47-95. 
Edidin, M. Timeline - Lipids on the frontier: a century of cell-membrane bilayers. Nature 
Reviews Molecular Cell Biology 2003, 4, 414-418. 
Furuya, A.; Uozaki, M.; Yamasaki, H.; Arakawa, T.; Arita, M.; Koyama, A. H. Antiviral 
effects of ascorbic and dehydroascorbic acids in vitro. International Journal of Molecular 
Medicine 2008, 22, 541-545. 
Gzyl-Malcher, B.; Filek, M.; Brezesinski, G. Influence of Cadmium and Selenate on the 
Interactions between Hormones and Phospholipids. Langmuir 2009, 25, 13071-13076. 
Halliwell, B. Role of free radicals in the neurodegenerative diseases - Therapeutic 
implications for antioxidant treatment. Drugs & Aging 2001, 18, 685-716. 
Halliwell, B.; Gutteridge, J. M. C., Free radicals in biology and medicine. 4th ed.; Oxford 
University Press: Oxford, 2007. 
Jariwalla, R. J.; Roomi, M. W.; Gangapurkar, B.; Kalinovsky, T.; Niedzwiecki, A.; Rath, M. 
Suppression of influenza A virus nuclear antigen production and neuraminidase activity 
by a nutrient mixture containing ascorbic acid, green tea extract and amino acids. 
Biofactors 2007, 31, 1-15. 
Kerksick, C.; Willoughby, D. The Antioxidant Role of Glutathione and N-Acetyl-Cysteine 
Supplements and Exercise-Induced Oxidative Stress. Journal of the International Society 
of Sports Nutrition 2005, 2. 
Reis, S.; Lúcio, M.; Segundo, M. A.; Lima, J. L. F. C., Use of liposomes to evaluate the role 
of membrane interactions on antioxidant activity. In Liposomes Methods and Protocols, 
Volume 2: Biological Membrane Models, Weissig, V., Ed. Springer, Humana Press: 
Clifton, N.J., 2010; Vol. 606, pp 167-188. 
Schief, W. R.; Touryan, L.; Hall, S. B.; Vogel, V. Nanoscale topographic instabilities of a 
phospholipid monolayer. Journal of Physical Chemistry B 2000, 104, 7388-7393. 
Sevanian, A.; Ursini, F. Lipid peroxidation in membranes and low-density lipoproteins: 
Similarities and differences. Free Radical Biology and Medicine 2000, 29, 306-311. 
Chapter 4 
 
110 
 
Sharma, M. K.; Buettner, G. R. Interaction of vitamin C and vitamin E during free radical 
stress in plasma: An ESR study. Free Radical Biology and Medicine 1993, 14, 649-653. 
Uchide, N.; Toyoda, H. Antioxidant Therapy as a Potential Approach to Severe Influenza-
Associated Complications. Molecules 2011, 16, 2032-2052. 
 
 
  
 
 
 
 
 
 
  
CHAPTER 5 
Evaluation of antioxidant capacity using 
lipidic biomimetic structures 
 
 
Chapter 5 
 
112 
 
5.Evaluation of antioxidant capacity using lipidic biomimetic 
structures 
 
 
5.1Introduction 
 
 
The assessment of antioxidant capacity is frequently required in different situations, 
namely for evaluation of nutritional composition of food products (Prior et al., 2005; 
Tabart et al., 2009), for evaluation of biological redox status (Valko et al., 2007) or for 
assessment of pharmacological effects of drugs (Fernandes et al., 2004; Magalhães et al., 
2007). According to Halliwell and co-workers (Halliwell and Gutteridge, 2007), an 
antioxidant in a biological system is “any substance that when present at low 
concentrations, compared to those of an oxidizable substrate significantly delays or 
prevents oxidation of that substrate”. Hence, according to this definition, not all 
reductants involved in a chemical reaction are antioxidants; only those compounds which 
are capable of protecting a biological target meet these criteria. This protection may be 
based on several mechanisms of action, namely: i) inhibition of generation and scavenging 
capacity against reactive species of oxygen or nitrogen; ii) reducing capacity; iii) metal 
chelating capacity; iv) activity as antioxidative enzyme; v) and inhibition of oxidative 
enzymes. 
Generally, the in vitro analytical methods for determination of antioxidant capacity aims 
at the first two mechanisms, relying on two different approaches, using competitive or 
non-competitive schemes (Magalhães et al., 2008). In the non-competitive assays, the 
antioxidant compounds interact with a reactive species, without any other competing 
target molecule in the reaction media. Therefore, these assays involve two components in 
the initial reaction mixture: the antioxidant compound(s) and the reactive species, which 
may also be the probe for reaction monitoring, as it happens for ABTS and DPPH assays 
(Brand-Williams et al., 1995; Re et al., 1999). These methods are quite popular for a 
primary screening of reducing capacity but they do not provide any information about real 
protection of biological targets. 
On the other hand, in assays based on competitive schemes, the target species, defined as 
a compound that represents a biomolecule which may be attacked in vivo, and the 
antioxidant compounds compete for the reactive species (radical or nonradicals). The 
assessment of antioxidant capacity is based on the quantification of a compound that 
facilitates the analytical measurement (probe). For instance, in the ORAC assay (Cao et al.,  
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1993), the probe is fluorescein, that is also the competing target species. Although this 
assay is frequently acknowledged as a suitable tool for evaluation of antioxidant capacity 
concerning the scavenging against peroxyl radical, fluorescein is not a biological target of 
oxidation. 
Moreover, recent work focusing on the evaluation of scavenging capacity against hydrogen 
peroxide (Ribeiro et al., 2010) showed that the direct reactivity towards hydrogen 
peroxide was higher for antioxidant compounds (glutathione and pyruvate) than for 
biological targets (cysteine, taurine and adenine). However, when a competitive scheme 
was applied, the scavenging effectiveness against hydrogen peroxide depended on the 
biological molecule present, showing that antioxidant assessment should also take into 
consideration the concomitant reactivity of biological molecules or structures that are 
prone to oxidative damage. 
Therefore, the aim of this work was to develop a methodology based on a competitive 
scheme with a biologically relevant target for assessment of scavenging capacity against 
peroxyl radicals. At the present time, no experimental model system has emerged yet as a 
‘‘gold standard’’ using biomimetic structures for evaluation of antioxidative capacity (Prior 
et al., 2005; Schnitzer et al., 2007) Until now, several lipidic structures have been assessed 
as potential targets for oxidation under competitive schemes, namely MLVs (Chaudhuri et 
al., 2009; Yin and Chan, 2007), LUVs (Dwiecki et al., 2009; Han et al., 2009), and SUVs 
(Fukuzawa et al., 2005; Hassimotto et al., 2005). However, no study comparing these 
structures under similar reaction conditions have been done so far to the best of our 
knowledge. Hence, we propose here the evaluation of EPC vesicles and 
hexadecylphosphocholine micelles as biological targets in a competitive adaptation of the 
ORAC assay. 
 
 
5.2 Reagents and solutions 
 
 
All chemicals used were of analytical reagent grade with no further purification. All 
chemicals used were of analytical reagent grade with no further purification. 2,2´-
Azobis(2-methylpropionamidine) dihydrochloride (AAPH), egg L-α-phosphatidylcholine 
(EPC), hexadecylphosphocholine, glutathione ascorbic acid and uric acid were from 
Sigma-Aldrich (St. Louis, MO). Fluorescein sodium salt and Trolox (6-hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid) were obtained from Fluka (Buchs, Switzerland). 
Water from Milli-Q system (resistivity > 18 MΩ cm) and absolute ethanol pro analysis 
(Panreac) was used for the preparation of all solutions. For preparation of vesicles, 
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methanol pro analysis from Merck (Darmstadt, Germany) and chloroform from Landilab 
(Porto, Portugal) were also used. 
The stock solution of uric acid (1000 µM) was prepared by dissolving 16.81 mg in 20 mL of 
0.01M NaOH. The excess of base was then neutralized with dropwise addition of 0.01M 
HCl until reaching pH 7.0. Finally, the volume was completed to 100 mL with water. Stock 
solutions of glutathione (1000 µM), ascorbic acid (1000 µM), and Trolox (500 µM) were 
prepared by dissolving the respective compound in water. Working standard solutions 
were prepared by rigorous dilution of the respective stock solution in buffer. 
 
 
5.3 Preparation of lipid structures 
 
 
For preparation of vesicles, the appropriate amount of EPC was dissolved in 10 mL of 
chloroform/methanol (3:1). This solvent was further evaporated under a nitrogen stream, 
where the resulting lipid film was left during at least 3 h to remove traces of the organic 
solvents. The dried lipid film was then dispersed in phosphate buffer (75 mM, pH 7.4) and 
the resulting mixture was vortexed to yield multilamellar vesicles (MLVs). This suspension 
was then extruded through polycarbonate filters using an extruder apparatus (Lipex 
Biomembranes, Vancouver, BC, Canada) to convert MLVs to LUVs. 
 
 
5.4 Assessment of antioxidant capacity 
 
 
The ORAC assay was implemented as a high-throughput 96-well microplate method. A 
microplate reader (H.T. Synergy, BIO-TEK) with excitation and emission wavelengths set 
at 485 ± 20 and 528 ± 20 nm, respectively, was used to monitor the oxidation of 
fluorescein and its prevention by tested antioxidants. 
Hence, a reaction mixture (300 µL) containing 40 nM of fluorescein, 36 mM of AAPH, 
and variable amounts of each biomimetic structure were prepared. For all assays, radical 
initiator solution was freshly prepared by dissolution of AAPH in pre-heated buffer at 37 
ºC before addition to microplate. Peroxyl radicals were generated at the beginning of the 
experiment by thermo-decomposition of AAPH at 37 ºC and at pH 7.4. For evaluation of 
antioxidant capacity, each antioxidant was added to the previously described reaction 
media, and the fluorescence intensity-time profile was followed up to 180 min. 
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Briefly, 50 µL of vesicles or micelles suspension were added to 100 µL of fluorescein 
solution. After that, 50 µL of test solution (Trolox or other antioxidants) were added and 
the mixture was shaken for 15 min at 37ºC before the addition of radical initiator. Finally, 
100 µL of AAPH was added to each well using a multichannel pipette. The decay in 
fluorescence intensity of fluorescein was monitored every minute during 180, beginning 
after the first minute of reaction. Blank experiments were prepared in the same way, but 
without the antioxidants studied. For this, 50 µL of buffer was added instead of Trolox or 
antioxidant solutions. To evaluate the stability of the fluorescence reporter upon the 
reaction time (control experiments), 100 µL of buffer was added instead of AAPH solution. 
Moreover, the potential intrinsic fluorescence of the tested antioxidants was measured in 
the absence of fluorescence probes and radical initiator. For all compounds tested, 
different concentrations were evaluated and the results obtained correspond to the mean 
of three or more independent experiments, performed in triplicate (n = 6). 
 
 
5.5 Calculation of antioxidant capacity as area under curve 
 
 
The lipid peroxidation induced by ROO• species was indirectly monitored by the 
fluorescence intensity decay of fluorescein. The data obtained for the fluorescence 
intensity decay were converted to relative fluorescence values, by dividing the fluorescence 
intensity at a given time by the fluorescence value attained after the first minute of 
reaction. The area under the curve (AUC) was calculated by integration of the curve 
obtained in the graphic representation of relative fluorescence values as a function of time. 
A linear relationship was established between AUC and antioxidant concentration (R2 > 
0.993; data not shown). Results obtained by the fluorimetric method correspond to the 
mean ± standard deviation of three experiments performed in triplicate (n = 9).  
 
 
5.6 Results and discussion 
 
 
5.6.1 Characterization of structures 
 
All vesicles and micelles applied as biomimetic lipidic targets were evaluated concerning 
their effective diameter and zeta-potential. MLVs, LUVs and SUVs presented an effective 
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diameter of 997 ± 20, 112 ± 4, and 104 ± 2 nm, respectively. These values are within the 
expected values for these types of structures. For micelles, two populations were found, 
with effective diameter of ca. 6.8 nm and 181 ± 2 nm. This deviation disappeared by 
submitting the micelle suspension to two consecutive extrusion cycles. 
Concerning the evaluation of zeta potential, the values obtained ranged from – 1.0 ± 0.9 to 
5.3 ± 1.7, indicating that all structures can be regarded as globally neutral. 
 
 
5.6.2 Oxidation profile of fluorescein probe 
 
 
The ORAC method was adapted here to the microplate format in presence of biomimetic 
structures. As depicted in Fig. 2, the probe oxidation followed a similar kinetic profile in 
presence of micelles and MLVs. For LUVs and SUVs, the oxidation of fluorescein was 
delayed because, for these two structures, the amount of lipid prone (or accessible) to 
attack by peroxyl radicals is higher than that found in MLVs, where several layers of lipid 
are trapped and protected inside the vesicle. Hence, in terms of effective concentration, 
there is more lipid contacting the aqueous phase in the small and large unilamellar 
vesicles. 
 
 
Figure 5.1 Fluorescein oxidation profile in presence of different biomimetic structures 
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5.6.3 Application to antioxidants 
 
 
The addition of Trolox into the reaction media resulted in the profiles depicted in Fig. 3 
where, for all conditions, a plateau corresponding to the first 20-40 minutes of reaction 
appeared when compared to the profile shown in Fig. 2. This delay on probe oxidation is 
due to peroxyl scavenging by Trolox. However, the profile is significantly different, 
depending upon the biomimetic lipidic structures present in the reaction media. Once 
again, the results for micelles and MLVs are quite similar, showing earlier probe oxidation  
when compared to the control performed in aqueous media. LUVs had a similar 
performance, with a slight delay on the last minutes of reaction. SUVs presented a 
remarkably different behavior, where the probe oxidation was significantly delayed. In 
opposition to what was first expected, probe oxidation in reaction media containing 
micelles, LUVs and MLVs took place before the control, probably because the lipidic 
structures, suffering from oxidation themselves, took an important role on peroxidation 
propagation. 
 
Figure 5.2 Fluorescein oxidation profile in presence of different biomimetic structures and 
antioxidant Trolox. 
 
Biologically relevant antioxidants were also tested, presenting the sensitivities (slope of 
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Table 5.1. Sensitivitya (relative fluorescence × min × µM-1) for antioxidants in presence of 
different biomimetic structures 
 No structure Micelles MLVs LUVs SUVs 
Trolox 271 ± 45 97 ± 11 85 ± 11 74 ± 5 295 ± 52 
Ascorbic acid 236 ± 67 75 ± 12 81 ± 11 66 ± 13 282 
Glutathione 98 ± 21 29 ± 4 24 ± 2 17 ± 4 112 
Uric acid 233 ± 4 101 ± 8 78 ± 2 108 ± 24 235 
a mean value from 10 (Trolox) or 3 (other compounds) independent experiments. 
 
In Table 6.2, the values for the ratio between the sensitivity attained by each antioxidant 
and the sensitivity presented by Trolox is given as a mean value of three independent 
experiment. For each experiment, Trolox was also processed, in order to eliminate biased 
results, sometimes attributed to the temperature dependent release of peroxyl radicals 
from AAPH. The relative reactivity is quite similar, except for glutathione in the presence 
of MLVs and LUVs that showed lower reactivity. An increased reactivity was presented by 
uric acid in reaction media containing LUVs. 
 
Table 5.2. Ratioa between the sensitivities attained for a given antioxidant and that 
attained by Trolox in presence of different biomimetic structures 
 
 No structure Micelles MLVs LUVs SUVs 
Ascorbic acid 0.78 ± 0.09 0.74 ± 0.04 0.88 ± 
0.09 
0.92 ± 0.13 0.84 
Glutathione 0.34 ± 0.02 0.28 ± 0.03 0.29 ± 0.02 0.24 ± 0.04 0.36 
Uric acid 1.02 ± 0.04 1.06 ± 0.07 1.01 ± 0.06 1.35 ± 0.29 1.00 
a mean value calculated from 3 independent experiments (except for SUVs), where the 
antioxidants and Trolox were analyzed simultaneously. 
 
 
5.7 Conclusions 
 
 
The methodology proposed here using a 96 well microplate format fostered the fast 
screening of scavenging capacity against peroxyl radicals in presence of biological targets. 
The miniaturization of the assay reduced its cost, leaving also a lower environmental 
footprint. Furthermore, a comparative evaluation of lipidic structures was performed, 
where vesicles prone to peroxidation and micelles structures were submitted to similar 
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reaction conditions in presence of a peroxidation inducer and antioxidants. The AUC, 
meaning the protection conferred by each antioxidant, was different for SUVs when 
compared to values obtained for other structures. Nevertheless, the relative antioxidant 
capacity of the tested compounds was quite similar, despite the lipidic structure tested. 
Future evaluation of this methodology using biological samples (serum, urina) will be 
undertaken. 
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High-throughput fluorimetric methodologies for assessment of 
antioxidant capacity of drugs at different locations of phospholipid 
bilayer 
 
 
6.1. Introduction 
 
 
The oxidative damage of polyunsaturated fatty acids of biomembranes is induced by an 
imbalance between the amount of reactive oxygen species (ROS) and/or reactive nitrogen 
species (RNS) produced and the antioxidant defenses. Among the reactive species formed, 
peroxyl radicals (ROO•) are the major oxidant species concerned in lipid peroxidation of 
biomembranes that disrupts their important structural, protective and functional role 
(Greig et al., 2012; Reis and Spickett, 2012). This pathologic process has been implicated 
in the etiology and/or in the development of several human diseases, such as chronic 
inflammation, cardiovascular and neurological disorders (Valko et al., 2007). Drugs used 
to correct and/or to treat these pathologies that present the additional property of prevent 
oxidative damage of biomolecules have been found to exhibit beneficial clinical effects 
(Tinkel et al., 2012). Actually, current therapeutic strategies are based on the design of 
multifunctional drug candidates that are able to interact with numerous disease related 
targets (Choudhary et al., 2012; Fernandez-Bachiller et al., 2012; Sawraj et al., 2012).  
In this context, the assessment of capacity of drugs to prevent oxidative damage of 
biotargets has received much attention in the last decade, which is mirrored in the large 
diversity of analytical methodologies that have been developed (Beretta and Facino). 
Among them, those assays that use liposomes as membrane models for lipid peroxidation 
studies provide an additional information of antioxidant capacity since it takes into 
account not only the intrinsic scavenging characteristics of drugs but also their location 
and interactions with phospholipid bilayers (Lucio et al., 2007). These assays are more 
biologically relevant compared to those relied on scavenging of stable non-biological 
radicals (DPPH• and ABTS•+) as well as those based on competitive assays performed in 
aqueous buffer media and using target molecules that do not represent any biomolecule 
found in living organisms (Beretta and Facino, 2010; Magalhaes et al., 2008). On the 
other hand, liposome based assays are cheaper and less affected by several uncontrolled 
factors compared to those performed with cells, animal models or human clinical trial 
studies. The analytical methodologies are based on the ability of test compounds to 
prevent and/or delay the oxidation of fluorescent probes used as reporters of lipid 
peroxidation induced by steady flux of ROO• radicals generated by thermo-decomposition 
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of azocompounds (Reis et al., 2010). The kinetic of oxidation of fluorescence probes and 
its prevention by tested compounds is monitored by the increase or the decrease of 
fluorescence intensity over the time. Several fluorescence probes with distinct lipophilic 
properties and therefore with different locations within liposomes have been used namely, 
the hydrophilic probes as fluorescein (Lucio et al., 2008; Santos et al., 2008) and 2,7-
dichlorodihydrofluoresecin (DCFH) (Li et al., 2009), the interface probe as hexadecanoyl 
aminofluorescein (HDAF) (Santos et al., 2008) and the lipophilic probes as 
diphenylhexatriene propionic acid (DPH-PA) (Lucio et al., 2008; Lucio et al., 2009), 
diphenyl-1-pyrenylphosphine (DPPP) (Tsuchiya et al., 2008; Tsuchiya et al., 2010) and 
4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-propionic acid 
(C11-Bodipy581/591) (Laszlo et al., 2012; Li et al., 2009; Takashima et al., 2012). Actually, 
previous works have explored the distinct lipophilic properties of fluorescence probes to 
correlate the antilipoperoxidant effect of drugs with their membrane location, membrane 
partition and the effect on membrane fluidity (Lucio et al., 2007; 2008; Lucio et al., 2009; 
Santos et al., 2008). Despite the feasibility of the mentioned lipid peroxidation assays, the 
long monitoring reaction times required for probe’s oxidation (usually >120 min) and the 
fact that a single cuvette in a dedicated spectrofluorimeter is used makes these assays 
time-consuming, laborious and with determination rate not suitable for routine/screening 
assays. Moreover, the dissimilar reaction conditions between assays namely, probe, lipid 
and radical initiator concentrations limit the comparison of data. The down-scale to a 
microplate format and the standardization of reaction conditions, meets the requirements 
of high-throughput data improving also the precision and accuracy. 
In the present work, we intend to develop simple, convenient and rapid 96-well microplate 
methodologies to assess the ability of drugs to counteract lipid peroxidation in different 
locations of phospholipid bilayer. For this, zwitterionic large unilamellar vesicles of egg L-
α-phosphatidylcholine were used as membrane mimetic systems, while a steady flux of 
ROO• radicals generated from the thermal decomposition of 2,2´-azobis(2-
methylpropionamidine) dihydrochloride (AAPH) was applied as the oxidant source. 
Different fluorescent probes with dissimilar locations in phospholipid bilayer were used, 
namely fluorescein and 5-dodecanoylaminofluorescein (DDAF) as fluorescent reporters in 
aqueous and in interface aqueous-lipid medium, respectively, while C11-BODIPY581/591 was 
used as lipophilic probe. As the antilipoperoxidant effects of drugs cannot be assured 
without analysis of the results obtained and experimental conditions used, the effects of 
concentration of probe, egg L-α-phosphatidylcholine of liposomes and radical initiator 
were studied. The antioxidant capacity of drugs was indirectly determined by their ability 
to prevent/delay the fluorescence intensity decay of the fluorescent probes, fluorescein 
and DDAF, or the fluorescence intensity increase of labeled liposomes with C11-
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BODIPY581/591. Some nonsteroidal anti-inflammatory drugs (NSAIDs) with different 
locations within lipid bilayer were used and their antioxidant capacity was related to that 
attained for Trolox, used here as antioxidant standard. 
 
 
6.2. Materials and methods 
 
 
6.2.1 Chemicals 
 
 
All chemicals used were of analytical reagent grade with no further purification. 2,2´-
Azobis(2-methylpropionamidine) dihydrochloride (AAPH), egg L-α-phosphatidylcholine 
(EPC), as well as nonsteroidal anti-inflammatory drugs tested namely etodolac (E0516), 
indomethacin (I7378), meloxicam sodium salt hydrate (M3935) and tolmetin sodium salt 
dihydrate (T6779)  were from Sigma-Aldrich (St. Louis, MO). Fluorescein sodium salt and 
Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) were obtained from 
Fluka (Buchs, Switzerland). 5-Dodecanoylaminofluorescein (DDAF) and 4,4-difluoro-5-
(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-propionic acid (C11-
Bodipy581/591) were obtained from Molecular Probes (Invitrogen Corporation, Carlsbad, 
CA, USA). Water from Milli-Q system (resistivity > 18 MΩ cm) and absolute ethanol pro 
analysis (Panreac) was used for the preparation of all solutions. For preparation of large 
unilamellar vesicles (LUVs), methanol pro analysis from Merck (Darmstadt, Germany) 
and chloroform from Landilab (Porto, Portugal) were also used. 
 
 
6.2.2 Preparation and fluorescence labeling of liposomes 
 
 
To prepare and label liposomes with DDAF or with C11-BODIPY581/591 fluorescence probes, 
the lipid solution in chloroform/methanol (3:1) and the fluorescence probe solution in 
methanol were dried together with nitrogen stream. After that, the lipid film was left 
under the same stream for at least 3 h to remove traces of the organic solvents. The 
resultant dried lipid film was dispersed into phosphate buffer (75 mM, pH 7.4) and the 
resultant mixture was vortexed to yield labeled multilamellar vesicles (MLVs). This 
suspension was then extruded through 100 nm pore size polycarbonate filters using an 
extruder apparatus (Lipex Biomembranes, Vancouver, BC, Canada) to convert MLVs to 
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large unilamellar vesicles (LUVs) labeled with probes, following a previously described 
procedure (Lucio et al., 2008; Lucio et al., 2009; Santos et al., 2008). Therefore, for 
experiments with DDAF and C11-BODIPY581/591, the probes were incorporated during LUV 
preparation. The fluorescent labeled LUVs were freshly prepared each day and protected 
from light. For assays using fluorescein as fluorescent probe, the resultant dried lipid film 
was dispersed into potassium phosphate buffer (75 mM, pH 7.4) and prepared in the same 
way but in the absence of the fluorescent probe. In fact, fluorescein solution was only 
added to the LUV suspension immediately before the measurements were taken.  
EPC concentration in vesicle suspensions was obtained by phosphate analysis using the 
phosphomolybdate method (McClare, 1971). Different ratios of lipid to fluorescence probe 
were tested, considering that for studies with lipophilic probes (DDAF and C11-
BODIPY581/591) the incorporation procedure was performed.  
 
 
6.2.3Microplate fluorimetric protocols for assessment of the 
antilipoperoxidant effects of drugs 
 
 
The capacity of NSAIDs to prevent lipid peroxidation of phospholipid bilayer (LUVs) was 
evaluated by high-throughput 96-well microplate fluorimetric procedures. Different 
fluorescent probes with dissimilar locations in lipid bilayer namely, fluorescein (aqueous 
medium), DDAF (interface) and C11-BODIPY581/591 (lipophilic medium) were used (Li et 
al., 2009; Santos et al., 2008). In all cases, ROO• radicals were generated by thermo-
decomposition of AAPH at 37 ºC and at pH 7.4. A microplate reader (H.T. Synergy, BIO-
TEK) with excitation and emission wavelengths set at 485 ± 20 and 528 ± 20 nm, 
respectively, was used to monitor the oxidation of probes and its prevention by drugs. 
Hence, a reaction mixture (300 µL) containing the following final concentrations of LUV 
suspension (800 µM) and AAPH (50 mM) was applied for all fluorescence probes tested. 
The concentration of fluorescein was fixed at 6 nM, while for experiments with DDAF and 
C11-BODIPY581/591, the concentration was fixed at 50 nM. For all assays, radical initiator 
solution was freshly prepared by dissolution of AAPH (50 mM) in pre-heated phosphate 
buffer at 37 ºC before addition to microplate. Briefly, 150 µL of fluorescence-labelled 
liposomes (DDAF and C11-BODIPY581/591 experiments) or 50 µL of non-labeled liposomes 
in addition 100 µL of fluorescein solution were placed in each well. After that, 50 µL of test 
solution (phosphate buffer, Trolox or NSAIDs) were added and the mixture was shaken for 
15 min at 37ºC before the addition of radical initiator. Finally, 100 µL of AAPH was added 
to each well using a multichannel pipette. The decay in fluorescence intensity of 
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fluorescein or DDAF was monitored every minute during 180 and 240 min, respectively, 
beginning after the first minute of reaction. The same approach was applied to lipophilic 
probe C11-BODIPY581/591, but in this case the fluorescence increase due to oxidation of 
probe was monitored during 90 min. Blank experiments were prepared in the same way, 
but without the drugs studied. For this, 50 µL of buffer was added instead of Trolox or 
NSAIDs solutions. To evaluate the stability of the fluorescence reporter upon the reaction 
time (control experiments), 100 µL of buffer was added instead of AAPH solution. 
Moreover, the potential intrinsic fluorescence of drugs was measured in the absence of 
fluorescence probes and radical initiator. For all drugs tested, different concentrations 
were evaluated and the results obtained correspond to the mean of two independent 
experiments, performed in triplicate (n = 6). 
 
 
6.2.4 Calculation of antioxidant capacity values expressed as IC50 or IC25 
 
 
The lipid peroxidation induced by ROO• species was indirectly monitored by the 
fluorescence intensity decay of probes (experiments with fluorescein and DDAF) or by the 
fluorescence intensity increase due to oxidation of C11-BODIPY581/591 (Li et al., 2009; 
Santos et al., 2008). The data obtained for the fluorescence intensity decay were converted 
to relative fluorescence values, by dividing the fluorescence intensity at given time (FIx min) 
by the fluorescence value attained at first minute (FI1 min) (equation 1): 
 
(FIx min / FI1 min) x 100
 
Eq. 1 
 
For the results obtained with lipophilic probe (C11-BODIPY581/591), the fluorescence 
intensity at a given time was divided by the maximum of fluorescence intensity obtained 
by probe’s oxidation in the absence of antioxidant species (blank experiments). Both 
values were subtracted by the intrinsic fluorescence intensity of C11-BODIPY581/591 
determined in the absence of radical species. The following equation (eq. 2) was used to 
express the kinetic profile of lipophilic probe oxidation upon reaction time: 
 
[(FIx min ‒ FIbodipy) / (FImax blank ‒ FIbodipy)] x 100
 
Eq. 2 
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The ability of Trolox and NSAIDs to prevent and/or delay the oxidation of probe was 
analysed considering the kinetic profile of probe’s oxidation in the presence and in the 
absence of drug during the reaction time. For experiments performed with fluorescein and 
DDAF as fluorescent probes, the area under the curve (AUC) obtained for sample and 
blank were assessed, since these parameter combines both inhibition time (correspondent 
to the initial plateau phase) and inhibition degree (correspondent to the decay profile) 
(Cao et al., 1993). These data were determined for each drug concentration tested and the 
antioxidant capacity (AC) was determined using the following equation: 
 
 
                                        
 
 
 
A linear relationship was established between antioxidant capacity (%) and drug 
concentration (R2 > 0.995; data not shown). The same approach was applied for 
experiments with C11-BODIPY581/591 in the presence of Trolox but in this case the area 
above the curve (ABC) was determined since when antioxidant is present the fluorescent 
product formed by probe’s oxidation is delayed.  The linear fits allowed the determination 
of the IC50 and IC25 values for NSAIDs, which are defined as the concentration (in µM) of 
each compound required to obtain a ratio of prevention of lipid peroxidation equal to 50 
or 25%, respectively (the latter was calculated when it became impossible to reach the IC50 
within the drug concentration range studied). Results obtained by these microplate 
fluorimetric methods correspond to the mean ± standard deviation of two experiments 
performed in triplicate (n = 6).  
 
 
6.3. Results and discussion 
 
 
In general, the assays used to determine the ability of drugs to prevent lipid peroxidation 
of phospholipid bilayers have the following components: i) a lipid structure to mimic 
phospholipid bilayer, usually large unilamellar vesicles (LUVs); ii) a thermal radical 
initiator to provide a steady flux of ROO• radicals in air-saturated solution; iii) an 
oxidation-sensitive fluorescent probe for reaction monitoring progress; iv) test compound 
that competes with probes for the radicals which prevents or retards the probe oxidation 
AC = 
AUCTrolox/NSAIDs ‒ AUCblank 
AUCblank 
X 100 
Eq. 3 
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and v) acquisition of reaction kinetics parameters, usually the area under curve, for 
assessment of antioxidant capacity (Reis et al., 2010). Therefore, the antilipoperoxidant 
effects determined depend on several factors, including the chemical composition and 
concentration of liposomes, the type and concentration of the inducer of peroxidation and 
the fluorescence reporter molecule selected (Schnitzer et al., 2007). In order to provide 
high-throughput and straightforward microplate assays for assessment the inhibition of 
lipid peroxidation in different locations of phospholipid bilayers a thorough analysis of 
these analytical parameters were studied.  
 
 
6.3.1 Influence of probe concentration 
 
 
The concentration of the probe determines the fluorescence intensity values of the 
methodology and the amount of radical species needed to oxidize almost all the sensitive 
fluorescent probe. Hence, higher probe concentrations provide higher analytical signals 
that present better reproducibility in inter and intraday assays, nevertheless higher 
amounts of radical species are required to guarantee that all fluorescent reporter 
molecules were oxidized. This matter implies higher amounts of antioxidants to protect 
fluorescence probes from oxidation, which could be difficult to perform due to limited 
solubility of drugs. Moreover, it is necessary to assure that the fluorescence probe is stable 
during the monitoring time. Taking into account theses issues, different concentrations of 
fluorescein (from 2.0 to 10.0 nM), DDAF (from 12.5 to 100 nM) and C11-BODIPY581/591 
(from 25 nM to 250 nM) were tested with fixed ratio of LUVs of EPC:probe (300:1). This 
ratio of lipid to probe was selected to prevent changes in the structure of the liposomes 
induced by the fluorescence probe (Lucio et al., 2007). Since the oxidized product of the 
lipophilic C11-BODIPY581/591 probe is the fluorescent compound monitored at the emission 
wavelength (528 ± 20 nm), AAPH (10 mM) was added to the reaction media. The results 
obtained for different concentrations of lipophilic probe tested are described in Figure 1. 
After reaching the maximum of fluorescence intensity due to the formation of the green 
fluorescent product a continuously decrease in fluorescence intensity was observed due to 
further oxidation of fluorescent product to non-fluorescent derivative (Drummen et al., 
2004). It is important to state here that neither C11-BODIPY581/591 nor its oxidation 
products are able to spontaneously leave the lipid bilayer (Drummen et al., 2002). For all 
probes tested, a linear relationship was established between fluorescence intensity and 
probe concentration (nM), providing a slope value of 7438 nM-1 for fluorescein (R = 
0.9985), 787 nM-1 for DDAF (R = 0.9991) and 232 nM-1 for C11-BODIPY581/591 (R = 
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0.99990). For fluorescein and DDAF, the decrease of fluorescence intensity during 
analysis time (180 and 240 min, respectively) due to photobleaching effects was < 15% 
(data not shown). Considering the aforementioned aspects, the concentrations of 
fluorescein, DDAF and C11-BODIPY581/591 selected for further studies were 6, 50 and 50 
nM, respectively. 
 
 
 
Figure 6.1. Fluorescence intensity upon reaction time for different concentrations of 
lipophilic probe C11-BODIPY581/591 obtained in the presence of 10 mM of AAPH. The 
concentration ratio between large unilamellar vesicles of egg L-α-phosphatidylcholine 
(EPC) and fluorogenic probe was fixed at 300:1, respectively. 
 
 
6.3.2 Influence of lipid and AAPH concentration 
 
 
The amount of large unilamellar vesicles of egg L-α-phosphatidylcholine (EPC) influence 
the fluorescence intensity of the oxidized product of the lipophilic probe C11-
BODIPY581/591, while for hydrophilic and interface fluorescent probes the fluorescence 
intensity obtained was independent of the concentration of EPC tested. Figure 2 describes 
the fluorescence intensity obtained for the different probes in the presence of increasing 
EPC concentrations, ranging from 100 to 1000 µM. In fact, for fluorescein and DDAF 
probes, the fluorescence intensity was similar for all EPC concentrations tested (p>0.05), 
but for lipophilic probe a fluorescence intensity increase was obtained up to 800 µM of 
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EPC (corresponding to 16000:1 of lipid: probe ratio). This dependency of fluorescence 
intensity of oxidized product of C11-BODIPY581/591 for lipid concentration is related to the 
necessity to have sufficient lipid to encompass the lipophilic fluorescent reporter and also 
to prevent the excimers formation (dimers oxidized C11-BODIPY581/591) that could interfere 
with the determination by self-quenching or by resonance energy transfer (Drummen et 
al., 2002). Considering that the EPC concentration affect the rate of lipid peroxidation 
(Schnitzer et al., 2007) and consequently the probe’s oxidation which could bias the 
antioxidant capacity data, the same EPC concentration (800 µM) was selected for all 
fluorescence probes. 
The addition of the ROO• generator (AAPH) to LUV suspensions, in the absence of 
antioxidant species (blank assay), has triggered the peroxidation of the probes yielding a 
gradual decay in fluorescence intensity of fluorescein and DDAF-labeled liposomes and a 
gradual increase in fluorescence intensity of C11-BODIPY581/591 labeled liposomes (Figure 
3). The kinetic of probe oxidation was dose-dependent of the initial AAPH concentration 
because it determines the rate of ROO• radical produced in aqueous media (Niki, 1990). 
Hence, for higher concentrations of AAPH, that yields higher amounts of ROO• radicals 
per time, the rate of probe oxidation measured by the fluorescence intensity decrease or 
increase was faster. Comparing the results obtained for fluorescein (used as hydrophilic 
probe) with that obtained with DDAF, which has a hydrophobic chain inserted into apolar 
part and the analogue fluorescein near the polar head groups of LUVs, the kinetic 
oxidation of fluorescein was higher. In fact, for similar initial AAPH concentration (150 
mM, Figure 6.3A (6), 6.3B (6)) about 60 min were necessary to oxidize fluorescein (6 nM) 
present in the aqueous phase, while for the interface fluorescent probe DDAF about 180 
min were required. This takes place because the major amounts of ROO• radicals are 
generated in the aqueous phase and therefore the fluorescein suffers oxidation easily than 
its analogue positioned in the interface of phospholipid bilayer. The lipophilic probe 
showed higher oxidation rate than DDAF due to the higher sensibility of C11-BODIPY581/591 
for peroxyl radicals (Drummen et al., 2002; Yoshida et al., 2003). Figure 3C shows that 
the maximum of fluorescence intensity obtained due to the formation of oxidized product 
of lipophilic probe was independent of the initial AAPH concentration,  but the time 
required to oxidize almost all probe decreased as the concentration of radical initiator 
increase. Moreover, the decline of fluorescence intensity due to further oxidation of 
fluorescent product of C11-BODIPY581/591 increase as the AAPH concentration increase; in 
fact for 75 mM of AAPH after 90 min there is no fluorescence intensity. Therefore, the 
application of high initial AAPH concentrations may oxidize the fluorescence probes in 
short reaction times, nevertheless to verify the prevention of probe oxidation by tested  
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Figure 6.2. Fluorescence intensity obtained for fluorescent hydrophilic probe 
(fluorescein), fluorescent interface probe (5-dodecanoylaminofluorescein, DDAF) and for 
fluorogenic lipophilic probe C11-BODIPY581/591 in the presence of different concentrations 
(µM) of large unilamellar vesicles of egg L-α-phosphatidylcholine (EPC). Fluorescein was 
added to LUV suspension immediately before the measurements, while the DDAF and 
C11-BODIPY581/591 were incorporated during vesicles preparation. For experiments using 
C11-BODIPY581/591, the concentration of peroxyl radical generator (AAPH) was fixed at 10 
mM. The circles show the EPC concentration selected for further studies. 
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Figure 6.3. Relative fluorescence intensity (%) of fluorescein (6 nM), DDAF (50 nM) and 
C11-BODIPY581/591 (50 nM) in the presence of large unilamellar vesicles of egg L-α-
phosphatidylcholine (EPC) (800 µM) and different concentrations (µM) of peroxyl radical 
generator AAPH: A) (1) 0, (2) 25, (3) 50, (4) 75, (5) 100, (6) 150, (7) 200; B) (1) 0, (2) 25, 
(3) 50, (4) 75, (5) 100, (6) 150; C) (1) 5; (2) 10, (3) 25, (4) 50, (5) 75. The arrows indicate 
the concentration of AAPH (50 mM) that was selected.  
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compounds, higher antioxidant concentrations are required. Regarding to the results 
obtained for the different fluorescence probes (Figure 3) and aiming to implement 
straightforward microplate procedures, the initial concentration of AAPH selected was 50 
mM, which at 37 °C corresponds to about 0.068 x 10-6  mol/L/s of ROO• radicals generated 
(Niki, 1990).  
 
 
6.3.4 Ability of NSAIDs to counteract lipid peroxidation in different locations 
of phospholipid bilayers 
 
 
To evaluate the applicability of the proposed fluorimetric methodologies for assessment of 
ability of drugs to prevent lipid peroxidation in different locations of phospholipid 
bilayers, some NSAIDs that have dissimilar partition coefficients in lipid-aqueous media 
were selected namely etodolac, indomethacin, meloxicam and tolmetin (see 
supplementary data, Figure S1). At pH 7.4, all drugs tested are predominantly negatively 
charged due to deprotonation of carboxyl groups (pKa < pH of the medium). 
Indomethacin is the most lipophilic drug due to its high partition coefficient determined 
in LUVs of EPC (Kp = 1442 ± 59) (de Castro et al., 2001) compared to that determined for 
meloxicam (Kp = 685 ± 70) (Lucio et al., 2007) and for tolmetin (Kp = 220 ± 70) (Lucio et 
al., 2004). Etodolac does not present partition into lipid bilayers of EPC in the 
concentration ranges used as it was previously described (Lucio et al., 2008). Therefore, in 
this case the drug concentrate preferentially in the aqueous phase and partly at the surface 
of LUVs with the negative charge of its molecule oriented toward the positive pole of the 
zwitterionic phosphatidylcholine head-group. For Trolox, used here as antioxidant 
standard compound, a 20% of partition in membrane/water system has been described in 
the literature (Barclay and Vinqvist, 1994). 
Figure 4A and 4B depicts the ability of indomethacin and tolmetin, respectively, to prevent 
fluorescein oxidation in the presence of LUVs of EPC. It can be observed that both drugs 
retards the oxidation of the aqueous fluorescent probe induced by ROO• radicals in a 
concentration-dependent manner. Figure 4C and 4D, shows the relationship between the 
antioxidant capacity (AC) and the concentration of the drug (µM). The AC was calculated 
as the percentage of increase of the area under curve (AUC) relative to that obtained for 
fluorescein in the absence of the drug (blank), which allows the assessment of IC50 values 
(concentration of drug that provide an AUC 50% higher of that obtained in the absence of 
drug). As it can be observed in Figure 4B, for highest concentrations of tolmetin (30 and 
40 µM) after 180 min of reaction monitoring, some fluorescein was not oxidized yet. This 
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issue can be easily observed by the deviation of the linearity in Figure 4D for the highest 
tolmetin concentrations. The same data treatment was performed for results obtained 
with DDAF-labeled liposomes. The results obtained for Trolox and tolmetin are described 
in Figure S2 (see supplementary data). Trolox avoided the immediate decay of 
fluorescence and lead to a plateau where the fluorescence is stable (similar results were 
obtained with fluorescein, data not shown). This fluorescence plateau corresponds to an 
inhibition time, after which the oxidation process starts over when there is no more 
antioxidant left to scavenge ROO• radicals. Taking into account that DDAF oxidation was 
slower than that attained for fluorescein (Figure 2) and that Trolox will retard probe’s 
oxidation, even after 240 min of reaction monitoring part of fluorescent probe was not 
oxidized (Figure S2, supplementary data). Hence, a deviation of linearity is attained which 
is aggravated for shorter reaction times, unless the AUC after reaction monitoring is 
considered (time > 240 min). This approach can be performed for Trolox because the 
kinetic of oxidation of probe is similar to that obtained for blank, but for almost all 
NSAIDs it cannot be applied since the plateau phase is not present and the kinetic of 
probe oxidation is different from that determined in the absence of drug (blank 
experiments). 
 
Figure 6.4. Relative fluorescence intensity (%) of fluorescein (A and B) and antioxidant 
capacity (C and D) obtained in the presence of different concentrations of indomethacin 
(0, 5, 10, 15, 20 µM) and tolmetin (0, 5, 10, 15, 20, 30, 40 µM) in large unilamellar vesicles 
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of EPC (800 µM) and with the AAPH concentration (50 mM). Antioxidant capacity was 
determined using the following equation, [(AUCTrolox/NSAIDs ‒ AUCblank) / (AUCblank)] x 100. 
For both drugs, AUC was calculated after 240 min. LUV:FL, correspond to the fluorescent 
intensity obtained by liposomes in the presence of aqueous fluorescent probe (fluorescein) 
in the absence of peroxyl radical species. 
The antioxidant capacity of drugs expressed as IC50 and IC25 (µM) in the presence of 
fluorescein and DDAF, respectively, as fluorescent probes are described in Table 1. Among 
the drugs tested, etodolac was the most potent scavenger preventing fluorescein and 
DDAF oxidation and therefore lipid peroxidation indirectly, as it can be observed for the 
lower IC values obtained (1.5 ± 0.2 µM and 12.0 ± 0.1 µM). Moreover, the antioxidant 
capacity of drugs was higher than that attained for antioxidant standard compound, 
Trolox. For all NSAIDs tested and Trolox, higher amounts of tested compounds were 
required to prevent oxidation of LUVs labeled with DDAF than for the same LUVs but 
with fluorescein in the aqueous media (increase of IC values). This takes place because 
higher concentrations of drugs are required to concentrate the drug at the surface of lipid 
bilayer and consequently prevent the oxidizable portion of the DDAF probe located at the 
interface lipid-aqueous phase, while for fluorescein the probe is present in the aqueous 
phase easily accessible to ROO• radicals and its prevention by drugs, especially those with 
lower partition coefficient as etodolac, meloxicam and tolmetin. These results are in 
accordance with those obtained for etodolac and Trolox using fluorescein and 
hexadecanoyl aminofluorescein (HDAF) as fluorescent probes (Lucio et al., 2008). For 
straightforward comparisons between assays, the IC of Trolox was divided by the IC values 
of NSAIDs (Table 1), considering that high values correspond to higher scavenger capacity 
of drug compared to Trolox. The ratio obtained for etodolac with fluorescein probe was 11, 
which means that IC50 of etodolac was about 11 times lower than that determined for 
Trolox, nevertheless with DDAF this ratio decreased to 2.9, which means that the efficacy 
of etodolac to prevent the oxidation of DDAF probe decreased relatively to Trolox. For 
meloxicam a decrease of this ratio was also observed, while for indomethacin it remains 
stable. These results are in accordance with the drug distribution in the lipid-aqueous 
phase compared to Trolox, hence for “hydrophilic” drugs this ratio decrease while for 
“lipophilic” drugs a stable value was obtained. Despite of tolmetin is also considered as a 
“hydrophilic” drug due to its lower partition coefficient compared to indomethacin, the 
ratio is similar for both fluorescent probes because this drug exists preferentially at the 
surface of lipid bilayer preventing DDAF oxidation (Nunes et al., 2011). Moreover, the 
lower pKa value (3.5) also justifies its predominance as negative molecule that binds to the 
positively charged groups of phospholipid bilayer. 
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Table 6.1. Peroxyl radical scavenging capacity of Trolox and nonsteroidal anti-
inflammatory drugs (NSAIDs) expressed as IC50 and IC25 values obtained with fluorescein 
and with 5-dodecanoylaminofluorescein (DDAF) as fluorescent probes.a 
 
  a Concentration of egg L-α-phosphatidylcholine liposomes (800 µM) and concentration of peroxyl radical 
generator  AAPH (50 mM). b IC values (µM) were calculated from the linear fit of (AUCNSAIDs ‒ 
AUCblankl)/AUCblank versus concentration of drug (µM); each value corresponds to the mean ± S.D. of two 
independent experiments performed in triplicate (n = 6). ICTrolox/ICNSAIDs, describes the peroxyl radical 
scavenging capacity of drugs related to Trolox (higher values correspond to high capacity to scavenge peroxyl 
radicals compared to Trolox). 
 
For lipophilic probe C11-BODIPY581/591 buried in the hydrophobic region of LUVs of EPC, 
the formation of oxidized green fluorescent product was monitored as the increase of 
fluorescence intensity at 528 ± 20 nm (Drummen et al., 2002; Li et al., 2009). The 
antioxidant behavior of Trolox was similar to that observed for the other fluorescent 
probes. The antioxidant standard avoided the immediate increase of fluorescence intensity 
(plateau phase), which after antioxidant depletion the kinetic of formation of oxidized 
product of C11-BODIPY581/591 was similar to that presented in the absence of antioxidant 
(Figure 5A). The subsequent formation of the non-fluorescent derivate compound formed 
by oxidation of green fluorescent product, which is observed by the decrease of 
fluorescence intensity after reach the maximum value, was not affected by the antioxidant 
compound. Hence, the antioxidant capacity of Trolox was determined as the area above 
curve (ABC) that reflects the ability of compound to protect C11-BODIPY581/591 for peroxyl 
radical oxidation. The IC50 value determined for Trolox was 1.9 ± 0.2 µM, which shows the 
potency of the antioxidant standard to prevent oxidation of the lipophilic probe. 
Nevertheless, when NSAIDs were analysed an effect different from that observed for 
 
Compounds Fluorescein 
(IC50, µM)b 
IC50, (Trolox) / 
IC50, (NSAIDs)  
DDAF 
(IC25, µM)b 
IC25, (Trolox) / 
IC25, (NSAIDs) 
Trolox 16.1 ± 0.8 1.0 34.6 ± 0.4 1.0 
NSAIDs     
Etodolac 1.5 ± 0.2 11 12.0 ± 0.1 2.9 
Indomethacin 7.8 ± 0.8 2.1 16.0 ± 0.4 2.2 
Meloxicam 4.3 ± 0.6 3.8 36.4 ± 0.9 1.0 
Tolmetin 6.4 ± 0.6 2.5 13.5 ± 0.4 2.6 
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Trolox was obtained, exemplified here for etodolac (Figure 5B) and for indomethacin 
(Figure 5C). In the case of etodolac (similar results were obtained for tolmetin and 
meloxicam), the kinetic of C11-BODIPY581/591 oxidation was not affected, but the maximum 
of fluorescence intensity obtained was higher than that observed in the absence of drug 
(blank). This takes place because under these reaction conditions (AAPH concentration), 
the drugs were not able to prevent probe’s oxidation due to its high sensitivity for ROO• 
radicals, but the further oxidation of fluorescent oxidized product of C11-BODIPY581/591 
was delayed providing therefore an increase of maximum of fluorescence intensity. For 
indomethacin, the kinetic of C11-BODIPY581/591 oxidation seems to be accelerated by 
increasing concentrations of drug, while the antioxidant effect toward fluorescent oxidized 
product was not observed. This result could be explained by the formation of fluorescent 
products resulting for indomethacin oxidation that interferes in the methodology or by the 
change of membrane fluidity mediated by the lipophilic drug that results in higher 
exposition of hydrophobic probe to ROO• generated in the aqueous media. 
Further investigation with this lipophilic probe is required to provide a suitable technique 
for measurement of ability of drugs to prevent lipid peroxidation in hydrophobic media of 
LUVs. Therefore, lower AAPH concentrations should be tested or the C11-BODIPY581/591 
oxidation should be monitored at its maximum emission at 595 nm (Drummen et al., 
2004; Drummen et al., 2002), instead of green fluorescent oxidized product at 520 nm, 
which is less sensible to probe’s oxidation and may circumvent the effects observed with 
oxidized fluorescent probe. 
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Figure 6.5. Relative fluorescence (%) intensity of lipophilic fluorogenic probe C11-
BODIPY581/591 in the presence of large unilamellar vesicles of EPC (800 µM), AAPH 
concentration (50 mM) and different concentrations of Trolox (0, 4, 8, 12, 16, 20 µM), 
etodolac (0, 5, 10, 15, 20, 30 µM) and indomethacin (0, 5, 10, 15, 20, 30 µM). The numbers 
(1 to 6) correspond to increasing concentrations of Trolox or NSAIDs. Relative 
fluorescence was determined by dividing the fluorescence intensity at a given time by the 
maximum of fluorescence intensity obtained for probe’s oxidation in the absence of 
antioxidant species (see section 2.4). 
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6.4. Conclusions 
 
 
Different microplate fluorimetric methodologies were implemented for high-throughput 
assessment of ability of drugs to prevent lipid peroxidation in different locations of 
phospholipid bilayer. The effect of some analytical parameters as fluorescence probe 
concentration, lipid concentration and initial concentration of radical initiator were 
evaluated aiming to attain uniformed microplate procedures to allow easy comparison of 
data. The ratio of IC values obtained for antioxidant standard (Trolox) and tested drugs 
permit this requirement. Among the drugs tested, etodolac was the most potent for 
prevention ROO• oxidation in aqueous and interface media using fluorescein and DDAF as 
fluorescent reporters.  
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7. General conclusions 
 
 
The potentialities of biophysical techniques, such as π-A isotherms and BAM imaging, 
were exploited in this work to try to shed some light on aspects related to peroxidation and 
antioxidant protection. For this, 2D (monolayers) and 3D (vesicles and micelles) 
biomimetic models of biological membranes were applied. In the first case, studies about 
the biophysical properties of phosphatidylcholine monolayers upon exposure to 
peroxidation conditions were performed. The interaction of several biologically relevant 
antioxidants (α-tocopherol, ascorbic acid, uric acid and glutathione) with membranes was 
clearly established by the observed changes in biophysical parameters and by formation of 
domains visualized by the BAM technique. 
Another important result from this thesis is the clear interaction established between the 
2D model applied here and the peroxidation products formed from derived species of 
AAPH, even in presence of antioxidants. This result is certainly relevant and should foster 
a deeper investigation about the nature of these products and the possibility of their 
selective extraction and concentration in the biological membrane. 
From an analytical point of view, the presence of biomimetic structures within the reaction 
media should be mandatory when antioxidant assessment is aimed. From our results, it 
was possible to show how the interactions of antioxidants (both endogeneous and 
exogenous) with the biological targets of oxidation may reveal a different behavior when 
compared to ideal analytical situations, when a single species is challenged in a rather 
simple medium, against a colored radical, for instance. 
For the future, it is clearly necessary to establish some order in this field because the 
literature is now filled with low quality data regarding antioxidant effects of nutrients, for 
instance, while the evaluation of redox status is disputable for many scientists. One of the 
main reasons for that is the inadequacy of methods applied for the target samples. Hence, 
standardization and clear discussion about the contextualization and implications of 
antioxidant assessment should be regarded as hot topics in a near future. 
 
 
